Page last updated: 2024-08-22

angiotensin ii and Cardiovascular Stroke

angiotensin ii has been researched along with Cardiovascular Stroke in 415 studies

Research

Studies (415)

Timeframe	Studies, this research(%)	All Research%
pre-1990	56 (13.49)	18.7374
1990's	101 (24.34)	18.2507
2000's	134 (32.29)	29.6817
2010's	92 (22.17)	24.3611
2020's	32 (7.71)	2.80

Authors

Authors	Studies
Bartosova, L; Galis, P; Goncalvesova, E; Klimas, J; Paulis, L; Rajtik, T	1
Bai, WW; Gao, CH; Guo, BX; Jiang, F; Li, C; Liu, KY; Qin, WD; Wang, H; Zhang, MX	1
Bajpai, G; Bredemeyer, A; Feng, G; Förster, I; Koenig, A; Kreisel, D; Lai, L; Lavine, KJ; Leuschner, F; Lokshina, I; Ma, P	1
Lin, L; Liu, A; Mei, Y; Xun, S; Zhang, Y; Zhou, G	1
Hua, D; Li, P; Li, Y; Mao, Y; Wu, X; Yong, Y; Zhao, K; Zhou, Z	1
Hu, J; Liu, Y; Wang, Q; Wang, W	1
Kawada, T; Li, M; Saku, K; Sawada, S; Suehara, S; Sugimachi, M; Uemura, K; Zheng, C	1
Ji, M; Li, Y; Liu, Y; Ma, G	1
Apte, SS; Bhutada, S; Chen, J; DeAngelo, LP; Gojanovich, GS; Hara, A; Heckl, JR; Hokutan, K; Jahansooz, JR; Kuwabara, JT; Lee, AY; Shettigar, V; Tacdol, DK; Tallquist, MD; Ziolo, MT	1
Duan, Y; Gu, H; Jiang, M; Li, S; Wang, C; Wang, Q; Yin, S; Zhen, W	1
Cui, Y; Song, X; Zhu, T	1
Ates, E; Kang, MJ; Mahmud, J; Seo, HS; Thi My Ong, H	1
Du, Z; Hao, Y; Li, W; Liang, Z; Liu, Y; Tao, Y; Wang, J; Yan, X; Yang, Y; Yu, J; Yuan, Y; Zhao, X	1
Gong, X; He, J; Li, Y; Lu, Y; Song, X	1
Liu, R; Xin, LH; Yang, XW	1
Jurado Acosta, A; Moilanen, AM; Ruskoaho, H; Rysä, J; Serpi, R; Szabo, Z	1
Ge, J; Ma, J; Ma, L; Ma, Y; Wu, R; Zou, Y	1
Finger, S; Garlapati, V; Karbach, SH; Knopp, T; Knorr, M; Kossmann, S; Lagrange, J; Molitor, M; Münzel, T; Nguyen, TS; Rudi, WS; Ruf, W; Schüler, R; Wenzel, P; Wild, J	1
Guo, H; Lu, T; Wang, C; Wang, H; Xing, D; Yang, J; Zhong, S	1
Brazhkina, O; Chandrabhatla, AS; Holmes, JW; Nelson, AR; Saucerman, JJ; Zeigler, AC	1
Aslam, N	1
Fukushima, A; Furihata, T; Kakutani, N; Kinugawa, S; Matsumoto, J; Nambu, H; Takada, S; Yokota, T	1
Azizi, M; Balavoine, F; Boitard, SE; Llorens-Cortes, C; Marc, Y	1
Liu, X; Long, F; Wang, J; Wang, Q; Yang, D; Zhu, M; Zhu, Y	1
Cui, SX; Doviak, H; Epstein, FH; French, BA; Leor, J; Sano, S; Shah, SA; Walsh, K; Wang, Y; Waters, CD	1
Li, Y; Liu, L; Ruan, Z; Wang, G; Wang, R; Zhu, L	1
Ahn, JH; Ahn, Y; Hong, YJ; Hur, SH; Hyun, JY; Jeong, MH; Kim, DI; Kim, JH; Kim, MC; Oh, SK; Park, HS; Sim, DS	1
Ali, Y; Dohi, K; Goto, I; Hashizume, R; Ito, M; Ito, R; Kobayashi, I; Kobayashi, Y; Nishikawa, M; Nishimura, Y; Okamoto, R; Saito, S; Sawa, Y; Tanaka, T; Yoshida, Y	1
Barreto-Chaves, MLM; Couto, GK; Fontes, MT; Lino, CA; Mill, JG; Paula, SM; Rossoni, LV; Senger, N	1
Li, D; Li, G; Lv, D; Ouyang, J; Peng, L; Shang, F; Wang, R; Yan, J; Yang, J	1
Alexis, JD; Ashton, JM; Burke, RM; Dirkx, RA; Lighthouse, JK; Mohan, A; O'Brien, M; Phipps, RP; Quijada, P; Small, EM; Woeller, CF; Wojciechowski, W	1
Ding, H; Li, J; Li, Y; Mei, Y; Wang, W; Zhang, R; Zhou, H	1
Cambrón-Mora, D; Garcia-Garduño, TC; Padilla-Gutierrez, JR; Valle, Y	1
Bhindi, R; Birgisdottir, AB; Bubb, KJ; Figtree, GA; Hansen, T; Karimi Galougahi, K; Kok, C; Meyer, C; Rasko, NB; Reisman, SA; Ritchie, R; Tang, O; Ward, K	1
Guo, L; Han, S; He, W; Li, H; Shen, D; Wang, J; Zhang, Y	1
Escobales, N; Javadov, S; Nuñez, RE	1
He, B; He, W; Hu, H; Jiang, H; Liu, S; Lu, Z; Luo, D; Ma, R; Qin, Z; Xie, J; Yu, X	1
Flores-Monroy, J; Lezama-Martínez, D; Martínez-Aguilar, L; Ramirez-Hernández, D; Samano-Hernández, C; Sampieri-Cabrera, R	1
Damen, FW; Goergen, CJ; Soepriatna, AH; Vlachos, PP	1
Gao, Y; Jiao, L; Liu, T; Shan, H; Shao, Y; Yang, B; Yin, H; Zhang, L; Zhang, Y	1
Correia, A; Ferreira, MPA; Gao, E; Hirvonen, J; Kinnunen, SM; Mäkilä, E; Ohukainen, P; Ruskoaho, H; Rysä, J; Salonen, J; Santos, HA; Serpi, R; Szabo, Z; Tölli, M; Välimäki, MJ	1
Liu, G; Yang, C; Yang, H; Yang, P; Yang, S; Zhao, D; Zheng, H	1
Meng, F; Tian, Z; Yan, M; Yang, P; Yang, S; Zhao, Z	1
Cao, Y; Jia, S; Liu, Y; Weng, L; Xu, C; Ye, J; Zheng, M	1
Bu, X; Duan, X; He, Y; Hu, H; Liu, H; Ming, X; Sun, S; Wu, Q; Yan, F; Zhu, H	1
Jing, Y; Liu, S; Ni, B; Zhou, D	1
Gong, H; Li, Y; Yang, C; Ye, Y; Yuan, J; Zhang, G; Zhang, X; Zou, Y	1
Okamura, K; Okuda, T; Shirai, K; Urata, H	1
Abraham, D; Acar, E; Costantino, S; Gonçalves, IF; Hallström, S; Hamza, O; Kiss, A; Klein, KU; Paneni, F; Podesser, BK; Szabo, PL; Tretter, EV; Trojanek, S	1
Chen, X; Li, C; Li, J; Sun, L; Wang, C; Xue, K; Yu, X; Zhang, J; Zhang, Q	1
Chen, AH; Ling, YN; Liu, HQ; Liu, QC; Song, XD; Wang, SY; Wang, XB; Wang, YX; Yan, J; Yan, JY; Yang, PZ; Zhang, Y	1
Li, Y; Lou, X; Lu, Y; Nasi-Er, BG; Sun, H; Tang, B; Zhang, J; Zhang, Y; Zhou, Q; Zhou, X	1
Guo, M; Ji, X; Liu, D; Xiao, J; Zhou, P	1
Chen, ML; Cheng, P; Gao, S; Lian, FZ; Ling, XX; Pan, M; Ruan, CS; Shen, AZ; Wang, XY	1
Benedict, C; Cheng, Z; Cimini, M; de Lucia, C; Garikipati, VNS; Goukassian, DA; Kishore, R; Koch, WJ; Lucchese, AM; Roy, R; Truongcao, MM; Wang, C	1
Ren, J; Song, H	1
Chu, ML; Dong, H; Khan, SA; Tsuda, T; Wu, J; Zhang, H	1
Ardell, JL; Beaumont, E; Hardwick, JC; Ryan, SE; Southerland, EM	1
Jiang, XJ; Li, XY; Ren, S; Wan, WG; Yi, X; Zhang, C; Zhang, XZ	1
Chen, H; Hu, X; Jiang, Z; Li, J; Liu, X; Steinhoff, G; Wang, L; Xu, Y; Yu, H; Zhang, Z	1
Alghamri, MS; Elased, KM; Grobe, N; Meszaros, JG; Morris, M	1
Chen, S; Guo, J; Jia, Y; Li, H; Liu, M; Liu, P; Liu, S; Ma, Y; Shao, W; Xu, J; Xu, S; Yu, N; Yue, Z; Zhang, B	1
Bin, J; Cao, S; Chen, B; Fu, Y; Huang, Q; Huang, X; Kitakaze, M; Liao, Y; Lu, D; Xu, D; Zhang, J	1
Cheng, W; Ge, J; Hou, Y; Hu, J; Li, Y; Lv, P; Niu, C; Wang, F; Yan, Y; Yang, Z	1
Calderone, A; Chabot, A; Dupuis, J; El Khoury, N; Fiset, C; Hertig, V; Jasmin, JF; Meus, MA; Nattel, S; Naud, P; Villeneuve, L	1
Bajulaiye, A; Libonati, JR; Mann, S; Muthukumaran, G; Sabri, A; Sturgeon, K	1
Flores-Monroy, J; Martínez-Aguilar, L; Valencia-Hernández, I	1
Chi, RF; Hu, XL; Li, B; Qin, FZ; Sun, Y; Tian, J; Xu, TR; Zhang, WF; Zhang, XL; Zhang, YA	1
Sui, X; Wang, D; Wei, H	1
Fan, Y; Hu, L; Li, QP; Liu, C; Song, YC; Wang, Y; Zhou, L; Zhu, HY	1
Ardell, JL; Hardwick, JC; Powers, EN; Ryan, SE; Southerland, EM	1
Chen, P; Li, X; Luo, J; Patterson, AJ; Xue, Q; Zhang, G	1
Guo, T; Hou, J; Huang, H; Long, H; Wang, J; Wang, T; Wu, Q; Xing, Y; Yan, P; Zheng, S; Zhong, T; Zhou, C	1
Chen, C; Li, R; Manso, AM; Ross, RS	1
Brandon-Warner, E; Bridges, CR; Fargnoli, AS; Hajjar, RJ; Katz, MG; Kendle, AP; Schrum, LW; Williams, RD	1
Chen, Y; Chen, YE; Fan, J; Kang, D; Li, S; Liu, E; Niimi, M; Ning, B; Shiomi, M; Wang, YN; Wang, Z; Waqar, AB; Yu, Q; Zhang, J	1
Akhtar, M; Hass, C; Khanam, R; Najmi, AK; Panda, BP	1
Guo, M; Ji, X; Sheng, X; Xiao, J; Zhang, X	1
Chang, H; Lin, CM; Shyu, KG; Wang, BW	1
Chen, W; Dong, H; Dong, S; Gao, X; Lv, G; Shao, S; Zhang, L	1
Bin, J; Chen, Z; Hao, H; Huang, X; Kitakaze, M; Li, Q; Li, X; Liao, W; Liao, Y; Lin, H; Xie, J; Xuan, W	1
De Meyer, GR; Martinet, W; Roth, L; Schrijvers, DM	1
Rao, SL; Wang, P; Yuan, YX; Zhu, XH	1
Jurado Acosta, A; Komati, H; Moilanen, AM; Nemer, M; Ruskoaho, H; Rysä, J; Szabo, Z	1
Bienvenu, LA; Delbridge, LM; Mellor, KM	1
Cai, X; Cao, H; Chen, X; Feng, J; Hong, Y; Song, H; Sui, L; Wang, Q; Ye, J; Zhang, X	1
Carreón-Torres, E; Del Valle-Mondragón, L; Díaz-Díaz, E; Guarner-Lans, V; Ibarra-Lara, L; Rubio-Ruiz, ME; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E; Vázquez-Meza, H	1
Gao, Y; Han, R; He, J; Kang, L; Li, C; Li, Y; Tian, J; Wang, J	1
Becari, C; Durand, MT; Oliveira, EB; Prado, CM; Ribeiro, MS; Salgado, HC; Salgado, MCO; Silva, MAB; Tostes, RC	1
Akazawa, H; Ikeda, Y; Isobe, M; Komuro, I; Koriyama, H; Kumagai, H; Maejima, Y; Morishita, R; Nakagami, H; Shimamura, M; Suzuki, JI; Wakayama, K; Watanabe, R	1
Cudnoch-Jedrzejewska, A; Dobruch, J; Kowalewski, S; Puchalska, L; Szczepanska-Sadowska, E; Ufnal, M; Wsół, A	1
Chen, S; Chen, Y; Dai, G; He, J; Huang, Y; Li, Z; Meng, R; Tang, L; Wang, L; Wu, Z; Xiao, P; Yao, F; Zhang, C	1
Sun, Y	2
Bai, SC; Deng, LH; Huang, P; Su, L; Wen, YW; Wu, ZL; Xu, DL	1
Chen, AD; Chen, Q; Gao, XY; Shi, Z; Wang, W; Xu, Y; Zhu, GQ	1
Szczepanska-Sadowska, E; Ufnal, M; Zera, T	1
Bjurgert, E; Cuthbertson, A; Hofstra, L; Indrevoll, B; Kindberg, GM; Krasieva, TB; Lovhaug, D; Narula, J; Narula, N; Petersen, LB; Petrov, AD; Reutelingsperger, CP; Solbakken, M; Tromberg, BJ; Vannan, MA; Verjans, JW	1
Campanelli, JJ; Christensen, LP; Dedkov, EI; Tomanek, RJ; Weiss, RM; Zhang, RL; Zheng, W	1
Cavallero, S; Gelpi, RJ; Gironacci, MM; González, GE; Krieger, ML; Lopez Verrilli, MA; Morales, C; Palleiro, J; Seropian, IM; Tomasi, VH; Wilensky, L	1
Baertschi, AJ; Isidoro Tavares, N; Lerch, R; Montessuit, C; Philip-Couderc, P	1
Huang, BS; Leenen, FH	1
Jia, T; Pamer, EG	1
Aikawa, E; Chudnovskiy, A; Cortez-Retamozo, V; Etzrodt, M; Figueiredo, JL; Kohler, RH; Libby, P; Mempel, TR; Nahrendorf, M; Panizzi, P; Pittet, MJ; Swirski, FK; Waterman, P; Weissleder, R; Wildgruber, M	1
Basu, R; Guo, D; Kassiri, Z; Liu, PP; Oudit, GY; Penninger, JM; Scholey, JW; Wang, X; Zhong, J	1
Aro, J; Leskinen, H; Mustonen, E; Pikkarainen, S; Pohjolainen, V; Ruskoaho, H; Rysä, J	1
Aro, J; Isopoussu, E; Leskinen, H; Mustonen, E; Ruskoaho, H; Rysä, J; Säkkinen, H; Tokola, H	1
Escher, F; Qian, C; Reudelhuber, TL; Roks, AJ; Schoemaker, RG; Schultheiss, HP; Schumacher, SM; Tschöpe, C; van Gilst, WH; Walther, T; Wang, Y; Westermann, D	1
Aro, J; Leskinen, H; Luosujärvi, H; Ruskoaho, H; Rysä, J; Skoumal, R; Szokodi, I; Tenhunen, O; Tokola, H	1
Bradley, EW; Dell'italia, LJ; Hase, N; Husain, A; Inoue, Y; Li, M; Naqvi, N; Powell, PC; Saku, K; Shi, K; Takahashi, Y; Urata, H; Wei, CC; Yahiro, E	1
Apablaza, F; Chiong, M; Godoy, I; Gonzalez, L; Hernandez, C; Jalil, JE; Lavandero, S; Lopez, R; Moya, J; Novoa, U; Ocaranza, MP; Pinto, M; Varas, M; Verdejo, H	1
Chen, BJ; Feng, JX; Gao, YL; Li, ZS; Meng, LQ; Su, XX; Xia, XL	1
Dai, HY; Deng, BP; Dong, B; Gao, F; Jiang, H; Liu, B; Liu, CX; Liu, DS; Liu, YF; Lu, XT; Pan, CM; Qiao, Y; Qu, X; Song, HD; Wang, LC; Yin, HQ; Yu, QT; Zhang, L; Zhang, MX; Zhang, YH; Zhao, YX	1
Dimaio, JM; Gerard, RD; Kinoshita, H; Kuwahara, K; Olson, EN; Richardson, JA; Sadek, H; Small, EM; Sutherland, LB; Thatcher, JE	1
Alhenc-Gelas, F; Bouby, N; Bruneval, P; Colucci, J; Griol-Charhbili, V; Krege, JH; Mandet, C; Messadi, E; Richer, C; Smithies, O; Vincent, MP	1
Miyoshi, A; Nakamura, Y; Sato, S; Shimizu, H; Suzuki, M; Takagi, Y	1
Chen, CX; Gu, WL; Liu, Y; Lü, J; Wu, Q; Zhang, SJ	1
Chen, WY; Dai, G; Leng, XY; Li, CL; Sun, XT; Tang, LL; Zeng, WT	1
Aoyama, T; Minatoguchi, S	1
Han, B; He, Y; Ma, J; Pan, Y; Peng, T; Wang, Y; Wei, M; Xin, P; Zhu, W	1
Cai, J; Li, X; Lu, X; Niu, K; Xin, W	1
Anastasia, L; Anversa, P; Cabral-Da-Silva, MC; Cappetta, D; D'Alessandro, DA; D'Amario, D; Ferreira-Martins, J; Fiorini, C; Goichberg, P; Hosoda, T; Kajstura, J; Leri, A; Michler, RE; Piccoli, M; Rota, M; Sanada, F; Steadman, E; Zheng, H	1
Aro, J; Leskinen, H; Levijoki, J; Manninen, A; Moilanen, AM; Mustonen, E; Ruskoaho, H; Rysä, J; Serpi, R; Tokola, H; Vuolteenaho, O	1
Li, D; Ma, S; Sun, M; Tang, B; Yang, D; Yang, Y	1
Han, B; Qu, S; Shi, Y; Sui, D; Yu, X	1
Hirooka, Y; Kishi, T; Ogawa, K; Sunagawa, K	1
Chen, CX; Huang, XY; Li, YM; Liu, Y; Wu, XM; Zhang, XM	1
Domińska, K; Drobnik, J; Ochędalski, T; Piastowska-Ciesielska, AW; Russell, JA; Zarzyńska, J	1
Chu, ML; Dong, H; Gao, E; Gao, F; Joyce, J; Koch, W; Liu, Y; Ma, X; Markova, D; Miller, T; Tsuda, T; Wu, J; Zhang, H; Zou, Y	1
Abe, J; Chang, E; Fujiwara, K; Heo, KS; Le, NT; Lee, H; Lu, Y; McClain, C; Molina, CA; Morrell, C; Oikawa, M; Patterson, C; Shishido, T; Takei, Y; Taunton, J; Tournier, C; Wang, X; Woo, CH; Yan, C; Yang, J	1
Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kolář, F; Kopkan, L; Kramer, HJ; Malý, J; Neckář, J; Netuka, I; Ošťádal, B; Papoušek, F	1
Araujo, AS; Barreto-Chaves, ML; Belló-Klein, A; Diniz, GP; Fernandes, RO; Ludke, AR; Ribeiro, MF; Schenkel, PC; Tavares, AM	1
Collier, P; McDonald, KM	1
Hamada, J; Kobara, M; Nakata, T; Noda, K; Shiraishi, T; Tanaka, T; Toba, H; Wang, J; Yoshifuji, Y	1
Feng, S; Lu, C; Lu, Y; Pan, Z; Ren, J; Shan, H; Sun, X; Wang, J; Wang, N; Wang, Y; Xie, L; Yang, B; Yuan, Y; Zhang, Y	1
Ardell, JL; Girasole, AE; Hardwick, JC; Negrotto, S; Ryan, SE; Southerland, EM	1
Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV	1
Benge, CD; Muldowney, JA	1
Deng, HY; Gong, QH; Huang, GY; Liu, XH; Pan, LL; Wu, D; Xiong, QH; Zhu, YZ	1
Idikio, H; Jugdutt, BI; Jugdutt, C; Menon, V; Palaniyappan, A; Uwiera, RR	1
Wang, W; Zhu, GQ; Zucker, IH	1
Imuro, Y; Iwasaka, T; Izuoka, T; Kitashiro, S; Mimura, J; Miyoshi, H; Saito, D; Takayama, Y; Tokioka, M; Yamamoto, S	1
Dendorfer, A; Dominiak, P; Hartmann, F; Jain, D; Katus, H; Kurz, T; Raasch, W; Richardt, G; Schäfer, U; Tölg, R	1
Alberts, G; Boomsma, F; de Zeeuw, S; Duncker, DJ; Lameris, TW; van den Meiracker, AH; Verdouw, PD	1
Aartsen, WM; Daemen, MJ; Danser, AH; Schuijt, MP; Smits, JF	1
Bader, M	1
Doggrell, SA	1
De Keulenaer, GW; Lee, RT; MacGillivray, C; Rouleau, JL; Shimpo, M; Solomon, SD; Tominaga, S; Weinberg, EO	1
Iwao, H; Izumi, Y; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M	1
Castillo, R; Deng, L; El-Adawi, H; El-Sherif, N; Ganguly, K; Mascareno, E; Smith, S; Tramontano, A	1
Gaede, P; Jensen, GV; Larsen, N; Parving, HH; Pedersen, O; Vedel, P	1
Matsuzaki, M; Nakamura, H; Takata, S; Umemoto, S	1
Sun, Y; Weber, KT	7
Chintalgattu, V; Katwa, LC; Nair, DM	1
Browne, AE; Chatterjee, K; Grossman, W; Karliner, JS; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ	1
Capponi, AM; Casal, AJ; Delcayre, C; Silvestre, JS	1
Gao, G; Huang, Y; Lei, L; Sun, X; Wang, S	1
Ciećwierz, D; Dubaniewicz, W; Gruchala, M; Grzybowski, A; Koprowski, A; Limon, J; Ochman, K; Romanowski, P; Rynkiewicz, A; Sobiczewski, W; Targoński, R; Wasag, B; Wojtowicz, A	1
Gaede, PH; Jensen, GV; Jepsen, PV; Larsen, JN; Parving, HH; Pedersen, OB	1
BEANLANDS, DS; GUNTON, RW	1
Egashira, K; Hayashidani, S; Ikeuchi, M; Matsusaka, H; Shiomi, T; Suematsu, N; Takeshita, A; Tsutsui, H; Wen, J	1
Kamper, AL; Karlsen, FM	1
Chen, WB; Fischer, JW; Kruse, ML; Petrik, C; Stoll, M; Stöter, K; Tiede, K; Ungefroren, H; Unger, T	1
Harada, M; Kitaura, Y; Komuro, I; Masaya, M; Minamino, T; Nagai, T; Sugaya, T; Terasaki, F; Toko, H; Zou, Y	1
Andersen, GS; Dahlström, U; Egstrup, K; Gøtzsche, O; Lahiri, A; Møller, JE; Skagen, K	1
Averill, DB; Brosnihan, KB; Ferrario, CM; Gallagher, PE; Ishiyama, Y; Tallant, EA	1
Ahmed, MS; Andersson, Y; Attramadal, H; Attramadal, T; Vinge, LE; Yndestad, A; Øie, E; Øystein Andersen, G	1
Ichikawa, Y; Miki, T; Miura, T; Nakamura, Y; Nakano, A; Shimamoto, K; Tsuchihashi, K	1
Ganten, D; Huang, BS; Leenen, FH; Wang, H	1
Chopra, K; Singh, D	1
Drexler, H; Fuchs, M; Grote, K; Hilfiker, A; Hilfiker-Kleiner, D; Kaminska, A; Kaminski, K; Kiian, I; Klein, G; Podewski, E; Wollert, KC	1
Azizi, M; Ménard, J	1
Jin, D; Miyazaki, M; Muramatsu, M; Okamoto, Y; Takai, S	1
Jin, H; Schwall, R; Wyss, JM; Yang, R	1
Burkhoff, D; Dickstein, M; Gu, A; He, KL; Maurer, M; Sabbah, HN; Wang, J; Wei, CM; Yi, GH	1
Arneja, AS; Dhalla, NS; Ganguly, PK; Netticadan, T; Shah, KR	1
Bertrand, ME	1
Ogawa, H; Yoshimura, M	1
Hattori, Y; Matsuda, N	1
Lu, L; Quinn, MT; Sun, Y	1
Dzau, VJ; McMurray, JJ; Pfeffer, MA; Swedberg, K	1
Bos, R; Findji, L; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM	1
Bertsche, T; Schulz, M	1
Burnier, M; Maillard, M; Meier, P	1
Kim, MP; Wahl, LM; Zhou, M	1
Berr, SS; Bishop, SP; Bove, CM; Dimaria, JM; Epstein, FH; French, BA; Gilson, WD; Kramer, CM; Scott, CD; Yang, Z	1
Battegay, E; Zeller, A	1
Deschamps, AM; Spinale, FG	1
Escobar, GP; Flack, EC; Goshorn, DK; Leonardi, RA; Lindsey, ML; Mains, IM; Mingoia, JT; Payne, JF; Sheats, NJ; Squires, CE	1
Doane, KJ; Folkesson, HG; Horne, WI; Maron, MB; Mase, SE; Meszaros, JG; Naugle, JE; Olson, ER; Pilati, CF; Zhang, X	1
Arita, M	1
Campbell, DJ; Chirkov, YY; Horowitz, JD; Rajendran, S	1
Borys, M; Gdowski, T; Kacprzak, P; Maczewski, M; Wojciechowski, D	1
Kim, HH; Liao, JK; Noma, K; Oyama, N; Rikitake, Y; Satoh, M; Wang, CY	1
Bel-Hadj, S; Calderone, A; Clement, R; Drapeau, J; El-Helou, V; Gosselin, H; Villeneuve, L	1
de Resende, MM; Kauser, K; Mill, JG	1
Fujioka, D; Kawabata, K; Kitta, Y; Kobayashi, T; Kodama, Y; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Takano, H; Umetani, K	1
Das, DK; Das, S; Engelman, RM; Maulik, N	1
Faramarzi, S; Grimm, D; Grosse, J; Habighorst, B; Infanger, M; J Danser, AH; Kossmehl, P; Kreutz, R; Kurth, E; Paul, M; Shakibaei, M; Wehland, M	1
Chen, J; Mehta, JL; Molavi, B	1
Hwang, GS; Koo, HN; Lee, BH; Oh, KS; Seo, HW; You, KH	1
Chakravarty, S; Dugar, S; Kerr, I; Li, Z; Ma, JY; Protter, AA; Schreiner, G	1
Boomsma, F; de Beer, VJ; Duncker, DJ; Haitsma, DB; Lamers, JM; Merkus, D; Sorop, O; Verdouw, PD	1
Jin, D; Miyazaki, M; Muramatsu, M; Takai, S	1
Cameron, VA; Collins, RP; Frampton, CM; Palmer, BR; Pilbrow, AP; Richards, AM; Skelton, L; Troughton, RW; Yandle, TG	1
Geng, DF; Jin, DM; Wang, JF; Wu, W; Wu, YM	1
Castro, P; Collantes, P; Copaja, M; Diaz-Araya, G; Godoy, I; Jalil, JE; Lavandero, S; Ocaranza, MP; Pinto, M; Ramirez, C; Roman, M; Varas, M	1
Hall, AS; Strauss, MH	1
Grassi, G	1
Almeida, AP; Araújo, CA; Caliari, MV; Ferreira, AJ; Jacoby, BA; Macedo, FA; Santos, RA; Silva, GA	1
Bell, RM; Clark, JE; Hearse, DJ; Shattock, MJ	1
de Resende, MM; Mill, JG	1
Dong, N; Fa, X; Hou, J; Zhang, R	1
Azuma, J; Dosaka, N; Iekushi, K; Katsuragi, N; Koibuchi, N; Morishita, R; Nagao, K; Ogihara, T; Sanada, F; Taniyama, Y	1
Carretero, OA; Cavasin, MA; Lin, CX; Reudelhuber, TL; Shesely, EG; Xu, J; Yang, JJ; Yang, XP	1
Cui, W; Li, M; Lu, XY; Wang, SR; Wang, ZT; Zhao, MJ; Zhu, LQ	1
Abrahamian, R; Bikhazi, AB; Bitar, KM; Der-Boghossian, AH; Issa, NG; Kadi, LN; Maharsy, WM	1
Brandes, RP	1
Bissessor, N; White, H	1
Victor, RG	1
Boomsma, F; de Beer, VJ; Dekkers, DH; Duncker, DJ; Lamers, JM; Merkus, D; Pijnappels, DA; Sorop, O	1
Diwan, V; Jaggi, AS; Khanna, G; Singh, M; Singh, N	1
Adrahtas, A; Cantwell, DM; Kompa, AR; Krum, H; Lewis, DA; See, F; Wang, BH	1
Ahmad, M; Huang, BS; Leenen, FH; Tan, J; White, R	1
Brenner, BM; Hostetter, TH; Ichikawa, I; Pfeffer, JM; Pfeffer, MA	1
Tarazi, RC	1
Cody, RJ	1
Lee, YA; Lindpaintner, K; Raman, VK	1
Brilla, CG; Maisch, B; Rupp, H; Weber, KT; Zhou, G	1
Hartman, JC	1
Peters, J	1
Cohen, MV; Downey, JM; Liu, Y; Tsuchida, A	1
Adamiak, D; Kregel, KC; Mott, A; Redlich, T; Stauss, HM; Unger, T; Zhu, YC	1
Falkenhahn, M; Gohlke, P; Paul, M; Stoll, M; Unger, T	1
Morgan, K	1
Sigurdsson, A; Swedberg, K	1
Alhenc-Gelas, F; Arnal, JF; Challah, M; Corvol, P; Huang, H; Llorens-Cortes, C; Michel, JB	1
Anversa, P; Capasso, JM; Li, P; Sonnenblick, EH	1
Pouleur, H	1
Drexler, H; Holtz, J; Meybrunn, M; Riede, UN; Schieffer, B; Seitz, S; Wirger, A	1
Ageev, FT; Belenkov, IuN; Dzhakhangirov, TSh; Gkhani, P; Lopatin, IuM; Mareev, VIu	1
Crozier, IG; Foy, SG; Frampton, CM; Ikram, H; Nicholls, MG; Richards, AM; Turner, JG	1
Ertl, G; Gaudron, P; Han, H; Hu, K; Neubauer, S; Tian, R	1
Lu, CY	1
Held, P; Sigurdsson, A; Swedberg, K	1
Berdeaux, A; Ghaleh, B; Giudicelli, JF; Richard, V	1
Andreasen, F; Böttcher, M; Christiansen, EH; Tian, R	1
Kim, S; Nishikimi, T; Takeda, T; Takeuchi, K; Yamagishi, H	1
Anversa, P; Capasso, JM; Li, P; Meggs, LG; Zhang, X	1
Diamant, D; Dzau, VJ; Ingelfinger, JR; Litwin, SE; Riegger, G; Schunkert, H; Tang, SS	1
Dzau, VJ	1
Held, P; Sigurdsson, A; Swedberg, K; Wall, B	1
Christie, J; Cobbe, SM; Connelly, DT; Dargie, HJ; Ford, I; Morton, JJ; Northridge, DB; Oldroyd, KG; Pye, M; Ray, SG	1
Arakawa, K; Ideishi, M; Ikeda, M; Noda, K; Sasaguri, M	2
Altieri, PI; Fernández-Martínez, J; González-Fernández, RA; Lugo, JE	1
Hartman, JC; Hullinger, TG; Shebuski, RJ; Wall, TM	1
Asakuma, S; Fujiwara, M; Iwasaki, T; Nakamura, K; Nakamura, T	1
Akioka, K; Hanatani, A; Iwao, H; Kim, S; Omura, T; Takeda, T; Takeuchi, K; Teragaki, M; Toda, I; Yoshiyama, M	1
Baker, KM; Booz, GW	1
Kass, DA; Recchia, FA; Saeki, A; Tunin, RS	1
Ball, SG; Hall, AS	1
Crake, T; Dalla Libera, L; Del Monte, F; Harding, S; Lefroy, DC; Poole-Wilson, PA; Vescovo, G	1
Compagnon, P; Desché, P; Devaux, B; Elfertak, L; Henry, JP; Macé, B; Mulder, P; Richard, V; Scalbert, E; ThuilleZ, C	1
Cleutjens, JP; Sun, Y; Weber, KT	1
Pfeffer, MA; Rouleau, JL; Vaughan, DE	1
Krasnikova, TL	1
Burrell, LM; Campbell, DJ; Duncan, AM; Kladis, A	2
Ikram, H	1
Abe, K; Jiang, ZL; Johnston, CI; Kamimoto, M; Kanazawa, M; Kohzuki, M; Sato, T; Wu, XM; Yasujima, M; Yoshida, K	1
Dixon, IM; Hata, T; Makino, N; Sugano, M; Yanaga, T	1
Abe, S; Kinukawa, N; Nakamura, M	1
Devaux, B; Henry, JP; Macé, B; Mulder, P; Richard, V; Thibout, E; Thuillez, C; Wimart, MC	1
De Carvalho Frimm, C; Sun, Y; Weber, KT	1
Riegger, GA	1
Cleutjens, JP; Katwa, LC; Sun, Y; Weber, KT	1
Angius, A; Balata, F; Cao, A; Cherchi, A; Cherchi, PA; Olla, N; Onnis, E; Pirastu, M; Poddie, D; Sole, G; Zedda, N	1
Campbell, SE; Katwa, LC	1
Ding, YA; Lee, YM; Peng, YY; Yen, MH	1
Busatto, VC; Cicilini, MA; Mill, JG	1
Carmines, PK; Didion, SP; Ikenaga, H; Mayhan, WG	1
Lavie, CJ; Malik, FS; Mehra, MR; Milani, RV; Re, RN	1
Miura, T; Nakano, A; Shimamoto, K; Suzuki, K; Ura, N	1
Dixon, IM; Jassal, DS; Ju, H; Zhao, S	1
Daemen, MJ; Heeneman, S; Leenders, PJ; Schiffers, PM; Smits, JF	1
Browne, AE; Chatterjee, K; Chou, TM; Deedwania, PC; Gao, L; Glantz, SA; Hutchison, SJ; Parmley, WW; Sievers, RE; Sudhir, K; Sun, YP; Zhu, BQ	1
Weber, KT	1
Ball, SG; Hall, AS; Megarry, SG; Sapsford, R	1
Cannizzaro, S; Di Pasquale, P; Iachininoto, R; Longo, AM; Maringhini, G; Paterna, S	1
Ford, WR; Jugdutt, BI; Khan, MI	1
Bahnson, TD; Gallagher, AM; Kim, NN; Printz, MP; Yu, H	1
Busatto, VC; de Moraes, AC; Gomes, Mda G; Milanez, Mda C; Mill, JG	1
Anversa, P; Cheng, W; Kajstura, J; Leri, A; Li, B; Liu, Y; Wang, X	1
Ramires, FJ; Sun, Y; Zhang, J; Zhang, JQ	1
Chang, J; Hilepo, J; Hirsch, L; Mento, PF; Pica, ME; Wilkes, BM	1
Chien, KR; Clark, RG; Hongo, M; Mao, L; McKirnan, MD; Ross, J; Sentianin, EM; Tanaka, N; Won, W	1
Remme, WJ	1
Barry, WH; Litwin, SE; Skolnick, RL; Spitzer, KW	1
Holtz, J	1
Gardemann, A; Haberbosch, W; Hehrlein, FW; Humme, J; Katz, N; Nguyen, QD; Rau, M; Stricker, J; Tillmanns, H	1
Chen, HF; Li, SM; Liu, B	1
Leenen, FH; Skarda, V; White, R; Yuan, B	1
Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Duncan, AM; James, GM; Kladis, A	1
Sharma, A; Singh, M	2
Huang, BS; Leenen, FH; Zhang, W	1
Bucca, V; Cannizzaro, S; Di Pasquale, P; Giubilato, A; Paterna, S; Scalzo, S	1
Aupetit-Faisant, B; Carayon, A; Delcayre, C; Heymes, C; Oubénaïssa, A; Robert, V; Silvestre, JS; Swynghedauw, B	1
Baba, T; Goto, Y; Miyazaki, S; Noguchi, T; Nonogi, H; Sumida, H; Yasuda, S	1
Gould, RJ; Grossman, W; Kusma, SE; Lynch, JJ; Painter, CA; Stump, GL; Thomas, JM; Wallace, AA	1
Huang, BS; Leenen, FH; Yuan, B	1
Pfeffer, MA	1
Haghfelt, T; Johansen, JB; Klitgaard, NA; Svanegaard, J; Thayssen, P	1
Browne, AE; Chatterjee, K; Chou, TM; Lee, RJ; Parmley, WW; Pulukurthy, S; Sievers, RE; Sudhir, K; Sun, Y; Zhu, B	1
Bernareggi, M; Berti, F; Berti, M; Colonna, VD; Del Soldato, P; Rossoni, G	1
Anversa, P; Fiordaliso, F; Kajstura, J; Latini, R; Leri, A; Li, B; Liu, Y; Malhotra, A	1
Cassat, C; Desachy, A; François, B; Gastinne, H; Normand, S; Vignon, P	1
Fukuma, T; Hasegawa, T; Miki, T; Miura, T; Nakano, A; Shimamoto, K; Tsuchida, A	1
Cleland, JG; Cockburn, N; Richardson, M	1
Carey, RM; Siragy, HM	1
de La Sierra, A; Ruilope, LM	1
Boer, P; Braam, B; Gröne, H; Hohbach, J; Joles, JA; Koomans, HA; Verhagen, AM	1
Boomsma, F; Danser, AH; Duncker, DJ; Haitsma, DB; Niebuur, R; Schalekamp, MA; Schuijt, MP; Stubenitsky, R; van Kats, JP; Verdouw, PD	1
Bulagannawar, M; Carretero, OA; Cavasin, MA; Karumanchi, R; Liu, YH; Mehta, D; Yang, XP	1
Califf, R; Edwards, S; Gallo, P; Henis, M; Leizorovicz, A; Maggioni, AP; McMurray, J; Neuhart, E; Pfeffer, MA; Rouleau, JL; Sellers, MA; Van De Werf, F; Velazquez, E	1
Dixon, IM; Hao, J; Jassal, DS; Jones, SC; Wang, B	1
Barthel, H; Gonzàlez, M; Obal, D; Preckel, B; Schlack, W; Thämer, V	1
Alvarez, R; Alvarez, V; Batalla, A; Celada, MM; Cortina, A; Coto, E; González, P; Hevia, S; Iglesias-Cubero, G; Medina, A; Reguero, JR	1
Sandmann, S; Unger, T; Yu, M	1
Beppu, S; Ishikura, F; Kobayashi, H; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M	1
Abraham, JA; Damm, D; Garrard, LJ; Henson, M; Joly, AH; Lam, A; Schreiner, GF; Stanton, LW; White, T	1
Brandstätter, K; Ertl, G; Hafner, M; Jacobs, M; Regitz-Zagrosek, V; Schorb, W; Staufenberger, S	1
Arakawa, K; Hoshino, F; Ideishi, M; Ihara, M; Kikuchi, M; Shirai, K; Suzumiya, J; Urata, H	1
McMurray, JJ	1
Aalkjaer, C; Blume, A; Bouzinova, E; Kaschina, E; Sandmann, S; Unger, T; Yu, M	1
McInnes, GT	1
Clanachan, AS; Ford, WR; Hiley, CR; Jugdutt, BI	1
Basdew, M; Danser, AH; de Vries, R; Saxena, PR; Schoemaker, RG; Schuijt, MP; van Veghel, R	1
Ajani, U; Arnold, M; Glynn, R; Greaves, S; Hall, C; Harel, F; Hennekens, C; Pfeffer, M; Rouleau, JL; Sirois, P; Solomon, S; White, M	1
Hasegawa, T; Kuno, A; Miki, T; Miura, T; Nishino, Y; Shimamoto, K; Tsuchida, A	1
Bofilis, E; Iliodromitis, EK; Karavolias, GK; Kremastinos, DT; Tasouli, A; Vlahakos, DV	1
Andreuzzi, B; Gronda, E; Mangiavacchi, M; Municinò, A	1
Browne, AE; Chatterjee, K; Lee, RJ; Parmley, WW; Sievers, RE; Sun, Y; Zhu, B	1
Bikhazi, AB; Birbari, AE; Bitar, KM; El-Sabban, ME; Hassan, KA	1
Browne, AE; Chair, K; Chatterjee, K; Glantz, SA; Hillman, RT; Lee, RJ; Parmley, WW; Sievers, RE; Zhu, BQ	1
Guo, Z; Lai, W; Li, J; Li, S; Liu, Y; Wu, P; Xiu, JC; Xu, JP; Zhang, Y	1
Bühler, FR	1
Brunner, H	1
Chernukh, AM; Gomazkov, OA; Shimkovich, MV	1
Lapshina, LA; Vlasenko, MA	1
Brown, JJ; Gavras, H; Gray, B; Kremer, D; Lever, AF; MacAdam, RF; medina, A; Morton, JJ; Robertson, JI	1
Abenhaim, L; Kuchel, O	1
Rossel's, AN; Salem, S	1
Kuczyńska-Sicińska, J	1
Kravchun, PG; Malaia, LT; Mikliaev, IIu; Naugol'nova, SB; Vlasenko, MA	1
Crexells, C; Diamond, G; Forrester, JS; Parmley, WW; Tomoda, H	1
Boucher, R; Genest, J; Kuchel, O; Nowaczynski, W; Rojo-Ortega, JM	1
Oberg, B	1
Cleutjens, JP; Daemen, MJ; Schoemaker, RG; Smits, JF; van Krimpen, C	1
Ball, SG	1
Fujii, T; Katayama, K; Kohno, M; Kusukawa, R; Matsuda, Y; Matsuzaki, M; Moritani, K; Ogawa, H	1
Jiang, M	1
Brunner, H; Doering, W; Kleber, FX; Niemöller, L; Nussberger, J	1
Daugherty, S; Fonken, SJ; Goldman, S; Lee, RW; Morkin, E; Raya, TE; Timmermans, PB; Wong, PC	1
Lamas, GA; Pfeffer, MA; Vaughan, DE	1
Dargie, HJ; Leckie, B; McAlpine, HM; Morton, JJ; Ray, SG	1
Bootsma, M; de Leeuw, PW; Kruijssen, DA; Look, MP; Remme, WJ	1
Sweet, CS	1
Dargie, HJ; McAlpine, HM; Morton, JJ	1
Dargie, HJ; Leckie, B; McAlpine, HM; Morton, JJ	1
Bel, KJ; de Graeff, PA; de Langen, CD; Kingma, JH; van Gilst, WH; Wesseling, H	1
Bondareva, ZG; Merzhievskaia, VM; Nikolaeva, AA; Oteva, EA; Popova, LV; Shterental', ISh	1
Hock, CE; Lefer, AM; Ribeiro, LG	1
Ding, YA; Shieh, SM; Tung, CS	1
Brenner, BM; Stanton, RC	1
Brenner, BM; Ichikawa, I; Kon, V; Pfeffer, JM; Pfeffer, MA	1
Brown, JJ; Gavras, H; Lever, AF; Macadam, RF; Robertson, JI	1
Kiseleva, ZM; Serebrovskaia, IuA; Uchitel', IA	1
Catt, KJ; Finnerty, FA; Mroczek, WJ	2
Elliott, K; Horrobin, DF; Jackson, FS; Manku, MS; McNeilly, AS; Nassar, BA; Reid, DS; Tynan, M	1
Faerchtein, I; Kastansky, I; Maciel, FS; Roque, AF	1
Gemperle, M; Megevand, R; Moret, PR	1
Adamska-Dyniewska, H	1
Clauss, RH; Ray, JF	1
Markiewicz, M	2
Chlup, J; Klener, P	1
Schröder, R	1
Grabovskiĭ, LA; Moĭbenko, AA	1
Jacobson, WW; Levinson, GE; Regan, TJ; Saffa, RS; Weisse, AB	1
Cha, HD; Grinnell, EH; Kramár, JL; Meyers, VW	1
Ellis, FH; Hallermann, FJ; McCallister, BD; Pairolero, PC; Titus, JL	2
Heublein, B; Parsi, RA	1
Chazov, EI	1
McCann, WD; O'Donovan, TP	1
Iio, M	1
Dennison, BH; Fuqua, JM; Hastings, FW; Malinin, TI; Speaker, DM; Weber, KT	1
Page, IH	1
Wood, JE	1
Hellstrom, HR	1
Austen, WG; Buckley, MJ; Gold, HK; Leinbach, RC; Mundth, ED; Sanders, CA	1
Boucher, R; Genest, J; Kuchel, O; Nowaczynski, W	1
Abinder, AA; Smolenskiĭ, VS	1
Contini, C; Corsi, C; L'Abbate, A; Maseri, A; Pesola, A	1

Reviews

70 review(s) available for angiotensin ii and Cardiovascular Stroke

Article	Year
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19. International journal of molecular sciences, 2021, Nov-26, Volume: 22, Issue:23 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Hypoxia; Lung; Myocardial Infarction; Peptide Fragments; Renin-Angiotensin System; SARS-CoV-2	2021
Computational model predicts paracrine and intracellular drivers of fibroblast phenotype after myocardial infarction. Matrix biology : journal of the International Society for Matrix Biology, 2020, Volume: 91-92 Topics: Angiotensin II; Animals; Cell Differentiation; Collagen; Computer Simulation; Endothelin-1; Extracellular Matrix; Fibroblasts; Gene Expression Regulation; Humans; Interleukin-1; Models, Biological; Myocardial Infarction; NF-kappa B; Paracrine Communication; Phenotype; Rats; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Wound Healing	2020
Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure. The Canadian journal of cardiology, 2020, Volume: 36, Issue:5 Topics: Angiotensin II; Angiotensin III; Animals; Antihypertensive Agents; Brain; Clinical Trials as Topic; Disulfides; Glutamyl Aminopeptidase; Heart Failure; Humans; Hypertension; Myocardial Infarction; Renin-Angiotensin System; Sulfonic Acids	2020
RAAS: A Convergent Player in Ischemic Heart Failure and Cancer. International journal of molecular sciences, 2021, Jul-01, Volume: 22, Issue:13 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Myocardial Infarction; Myocardial Ischemia; Neoplasms; Renin; Renin-Angiotensin System	2021
Integrins and integrin-related proteins in cardiac fibrosis. Journal of molecular and cellular cardiology, 2016, Volume: 93 Topics: Age Factors; Aging; Angiotensin II; Animals; Blood Pressure; Carrier Proteins; Cytokines; Diabetic Cardiomyopathies; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Integrins; Molecular Targeted Therapy; Myocardial Infarction; Myocardium; Protein Binding; Stress, Mechanical	2016
Myocardial repair/remodelling following infarction: roles of local factors. Cardiovascular research, 2009, Feb-15, Volume: 81, Issue:3 Topics: Angiotensin II; Animals; Cell Death; Fibrosis; Heart Failure; Humans; Inflammation; Myocardial Infarction; Myocardium; Oxidative Stress; Prognosis; Reactive Oxygen Species; Signal Transduction; Ventricular Remodeling	2009
The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Current heart failure reports, 2009, Volume: 6, Issue:2 Topics: Angiotensin II; Brain; Heart Failure; Humans; Myocardial Infarction; Renin-Angiotensin System; Sympathetic Nervous System; Ventricular Dysfunction, Left; Ventricular Remodeling	2009
[The effect of ARB on prevention of atherosclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2011
The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction population. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hypertension; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Valine; Valsartan	2012
Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. Journal of molecular and cellular cardiology, 2002, Volume: 34, Issue:11 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Cardiomegaly; Fibrosis; Heart; Hypertension; Mice; Mice, Knockout; Mice, Transgenic; Models, Biological; Myocardial Infarction; Myocardium; Organ Specificity; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Stress, Mechanical; Ventricular Remodeling	2002
Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease? Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cough; Diabetes Complications; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Receptor, Angiotensin, Type 1	2002
RAS and connective tissue in the heart. The international journal of biochemistry & cell biology, 2003, Volume: 35, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Connective Tissue; Enzyme Inhibitors; Humans; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System	2003
[Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?]. Ugeskrift for laeger, 2003, Oct-13, Volume: 165, Issue:42 Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Humans; Kidney Failure, Chronic; Myocardial Infarction; Proteinuria; Receptors, Angiotensin; Renin-Angiotensin System	2003
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation, 2004, Jun-01, Volume: 109, Issue:21 Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Diabetic Nephropathies; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proteinuria; Rats; Renin-Angiotensin System; Ventricular Dysfunction, Left	2004
Chymase-derived angiotensin II and arrhythmias after myocardial infarction. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2004, Volume: 124, Issue:2 Topics: Angiotensin II; Arrhythmias, Cardiac; Chymases; Enzyme Activation; Humans; Myocardial Infarction; Serine Endopeptidases	2004
The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure. Current pharmaceutical design, 2004, Volume: 10, Issue:20 Topics: Angiotensin II; Animals; Disease Models, Animal; Heart Failure; Hepatocyte Growth Factor; Humans; Myocardial Infarction	2004
Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Current medical research and opinion, 2004, Volume: 20, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Cardiovascular Diseases; Clinical Trials as Topic; Heart Arrest; Humans; Hypertension; Myocardial Infarction; Oxidative Stress; Risk Factors; Vasodilation	2004
[Natriuretic peptides in patients with ischemic heart disease]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Angina, Unstable; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Cytokines; Humans; Inflammation Mediators; Myocardial Infarction; Natriuretic Peptide, Brain; Ventricular Remodeling	2004
[Mitogenic action of endothelin on fibroblasts]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Angiotensin II; Animals; Cell Division; Collagen; Endothelin-1; Extracellular Matrix; Fibroblast Growth Factor 2; Fibroblasts; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Liver Cirrhosis; Myoblasts, Cardiac; Myocardial Infarction; Pulmonary Fibrosis; Receptors, Endothelin; Transforming Growth Factor beta; Ventricular Remodeling	2004
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation, 2004, Nov-16, Volume: 110, Issue:20 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Heart Failure; Humans; Hypotension; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Spironolactone; Ventricular Dysfunction, Left	2004
[Angiotensin receptor antagonists. A clinical-pharmacologic overview]. Medizinische Monatsschrift fur Pharmazeuten, 2005, Volume: 28, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Diabetic Nephropathies; Humans; Kidney Diseases; Migraine Disorders; Myocardial Infarction	2005
The future of angiotensin II inhibition in cardiovascular medicine. Current drug targets. Cardiovascular & haematological disorders, 2005, Volume: 5, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Protease Inhibitors; Renin; Risk Factors	2005
[Angiotensin II receptor blockers--evidence along the cardiovascular continuum]. Praxis, 2005, Apr-13, Volume: 94, Issue:15 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dogs; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Placebos; Rabbits; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Stroke; Tetrazoles; Time Factors	2005
Disruptions and detours in the myocardial matrix highway and heart failure. Current heart failure reports, 2005, Volume: 2, Issue:1 Topics: Angiotensin II; Disease Progression; Endothelin-1; Extracellular Matrix; Heart Failure; Humans; Hypertrophy, Left Ventricular; Integrins; Matrix Metalloproteinases; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Ventricular Remodeling	2005
[Angiotensin I, angiotensin II, angiotensin III]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 8 Topics: Angiotensin I; Angiotensin II; Angiotensin III; Biomarkers; Chromatography, High Pressure Liquid; Cushing Syndrome; Diagnosis, Differential; Diagnostic Techniques, Endocrine; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Myocardial Infarction; Radioimmunoassay; Reference Values; Renin-Angiotensin System; Specimen Handling; Water-Electrolyte Imbalance	2005
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Pharmacology & therapeutics, 2006, Volume: 112, Issue:3 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Aortic Aneurysm; Chymases; Fibrosis; Heart Diseases; Humans; Hypertension; Mast Cells; Myocardial Infarction; Neovascularization, Pathologic; Serine Proteinase Inhibitors	2006
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction. Vascular health and risk management, 2007, Volume: 3, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Renin-Angiotensin System; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left	2007
Pathophysiology of target-organ disease: does angiotensin II remain the key? Journal of clinical hypertension (Greenwich, Conn.), 2007, Volume: 9, Issue:11 Suppl 4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Disease Progression; Humans; Hypertension; Losartan; Myocardial Infarction; Renin; Renin-Angiotensin System; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan	2007
Renin, angiotensin, and cardiac lesions. The Journal of laboratory and clinical medicine, 1980, Volume: 95, Issue:2 Topics: Angiotensin II; Animals; Arteriosclerosis; Cardiomyopathies; Catecholamines; Endothelium; Heart Ventricles; Humans; Hypertension; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Protein Biosynthesis; Rabbits; Rats; Renin	1980
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review. Drugs, 1984, Volume: 28, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide	1984
The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy. The American journal of cardiology, 1995, Nov-02, Volume: 76, Issue:13 Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Cardiomegaly; Humans; Hypertension; Myocardial Infarction; Myocardium; Renin-Angiotensin System	1995
Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. The American journal of cardiology, 1995, Nov-02, Volume: 76, Issue:13 Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibody Formation; Collagen; Collagenases; Connective Tissue; Dinoprostone; Endomyocardial Fibrosis; Fibroblasts; Heart Failure; Humans; Hypertension; Matrix Metalloproteinase 1; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Renin-Angiotensin System; Ventricular Dysfunction, Left	1995
Molecular basis of human hypertension: the role of angiotensin. Bailliere's clinical endocrinology and metabolism, 1995, Volume: 9, Issue:3 Topics: Angiotensin II; Angiotensinogen; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Peptidyl-Dipeptidase A; Pre-Eclampsia; Pregnancy; Receptors, Angiotensin; Renin; Renin-Angiotensin System	1995
The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. Journal of cardiovascular pharmacology, 1994, Volume: 24 Suppl 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Coronary Disease; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System	1994
Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies. British heart journal, 1994, Volume: 72, Issue:3 Suppl Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Endothelium, Vascular; Gene Expression; Heart Failure; Humans; Myocardial Infarction; Peptidyl-Dipeptidase A; Renin-Angiotensin System	1994
Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure? British heart journal, 1994, Volume: 72, Issue:3 Suppl Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sympathetic Nervous System; Ventricular Dysfunction, Left	1994
Role of neurohormones in ventricular adaptation and failure. The American journal of cardiology, 1994, Apr-07, Volume: 73, Issue:10 Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Hormones; Humans; Myocardial Infarction; Ventricular Function, Left	1994
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Basic research in cardiology, 1993, Volume: 88 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Endothelium, Vascular; Heart; Humans; Muscle, Smooth, Vascular; Myocardial Infarction; Peptidyl-Dipeptidase A; Renin-Angiotensin System	1993
Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovascular research, 1995, Volume: 30, Issue:4 Topics: Angiotensin II; Animals; Collagen; Fibroblasts; Gene Expression; Heart; Hypertension; Myocardial Infarction; Rats; Signal Transduction	1995
Clinical background to the use of ACE inhibitor therapy after myocardial infarction. Journal of cardiovascular risk, 1995, Volume: 2, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Long-Term Care; Myocardial Infarction; Recurrence; Survival Rate	1995
Tissue angiotensin II and myocardial infarction. EXS, 1996, Volume: 76 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Collagen; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Tissue Distribution; Wound Healing	1996
Structural remodeling of the infarcted rat heart. EXS, 1996, Volume: 76 Topics: Aldosterone; Angiotensin II; Animals; Collagen; Fibrosis; Humans; Metalloendopeptidases; Myocardial Infarction; Myocardial Ischemia; Myocardium; Rats; Renin-Angiotensin System; Wound Healing	1996
Role of the fibrinolytic system in preventing myocardial infarction. European heart journal, 1995, Volume: 16 Suppl K Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Fibrinolysis; Humans; Myocardial Infarction; Renin-Angiotensin System	1995
[Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy]. Klinicheskaia meditsina, 1996, Volume: 74, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Imidazoles; Kidney Diseases; Losartan; Myocardial Infarction; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors	1996
The renin-angiotensin-aldosterone system and cardiac ischaemia. Heart (British Cardiac Society), 1996, Volume: 76, Issue:3 Suppl 3 Topics: Angina Pectoris; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Blood Flow Velocity; Coronary Vessels; Dogs; Humans; Myocardial Infarction; Myocardial Ischemia; Rats; Renin-Angiotensin System; Vasoconstriction	1996
Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease. Cardiovascular drugs and therapy, 1996, Volume: 10 Suppl 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Coronary Disease; Humans; Hypertension; Morbidity; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renin-Angiotensin System; Risk Factors	1996
Tissue repair and angiotensin II generated at sites of healing. Basic research in cardiology, 1997, Volume: 92, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Models, Cardiovascular; Myocardial Infarction; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Wound Healing	1997
Renin-angiotensin system: genes to bedside. American heart journal, 1997, Volume: 134, Issue:3 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Arteriosclerosis; Blood Pressure; Cardiomyopathy, Dilated; Cardiovascular Diseases; Constriction, Pathologic; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Recurrence; Renin-Angiotensin System	1997
Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation, 1997, Dec-02, Volume: 96, Issue:11 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Female; Fibrosis; Heart Failure; Humans; Myocardial Infarction; Myofibrils; Peptidyl-Dipeptidase A; Ventricular Dysfunction, Left	1997
Do ACE inhibitors provide protection for the heart in the clinical setting of acute myocardial infarction? Drugs, 1997, Volume: 54 Suppl 5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Clinical Trials as Topic; Heart; Humans; Myocardial Infarction; Myocardium; Necrosis; Renin-Angiotensin System; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left	1997
Local angiotensin II and myocardial fibrosis. Advances in experimental medicine and biology, 1997, Volume: 432 Topics: Angiotensin II; Animals; Collagen; Endomyocardial Fibrosis; Heart; Humans; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Receptors, Angiotensin; Wound Healing	1997
Effect of ACE inhibition on neurohormones. European heart journal, 1998, Volume: 19 Suppl J Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Controlled Clinical Trials as Topic; Humans; Myocardial Infarction; Myocardial Ischemia; Norepinephrine; Peptidyl-Dipeptidase A	1998
Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones. Annals of medicine, 1998, Volume: 30 Suppl 1 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Endomyocardial Fibrosis; Female; Humans; Male; Myocardial Infarction; Prognosis; Renin-Angiotensin System; Ventricular Remodeling	1998
Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction. Basic research in cardiology, 1998, Volume: 93 Suppl 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Cardiomegaly; Humans; Myocardial Infarction; Myocardium; Renin-Angiotensin System	1998
Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers. American heart journal, 2000, Volume: 139, Issue:1 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Heart Failure; Humans; Myocardial Infarction; Prognosis; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Tetrazoles; Valine; Valsartan; Ventricular Function, Left	2000
Infarct scar: a dynamic tissue. Cardiovascular research, 2000, Volume: 46, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cicatrix; Collagen; Extracellular Matrix; Fibroblasts; Humans; Myocardial Infarction; Myocardium; Necrosis; Neovascularization, Pathologic; Transforming Growth Factor beta; Wound Healing	2000
Prospective trials of angiotensin receptor blockers: beyond blood pressure control. Current hypertension reports, 2000, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Hypertension; Losartan; Myocardial Infarction; Tetrazoles; Valine; Valsartan	2000
Treatment of hypertension in diabetes mellitus. Current hypertension reports, 2000, Volume: 2, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors	2000
Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction. Heart (British Cardiac Society), 2001, Volume: 86, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Heart Failure; Humans; Losartan; Models, Cardiovascular; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles	2001
Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist? Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2001, Volume: 19, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Myocardial Infarction; Renal Insufficiency; Renin-Angiotensin System	2001
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:12 Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Death, Sudden, Cardiac; Diuretics; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Pacemaker, Artificial; Prognosis; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Spironolactone; Vasodilator Agents	2001
[Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering]. Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1977, Volume: 43 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Bradycardia; Cardiac Output; Catecholamines; Cats; Dogs; Humans; Hypertension; Kinetics; Myocardial Infarction; Norepinephrine; Pressoreceptors; Rabbits; Renin; Vascular Resistance	1977
[Prostaglandins, kallikrein-kinin and dopamine. Practical implications of this vasodilator-natriuretic system]. L'union medicale du Canada, 1979, Volume: 108, Issue:6 Topics: Aldosterone; Angiotensin II; Anti-Inflammatory Agents; Arachidonic Acids; Bartter Syndrome; Bradykinin; Dopamine; Edema; Humans; Hyperaldosteronism; Hypertension; Hypotension, Orthostatic; Kallikreins; Kidney; Kinins; Myocardial Infarction; Natriuresis; Prostaglandins; Receptors, Dopamine; Renin; Thromboxane A2; Vasodilation	1979
[Side effects of oral contraceptives]. Polskie Archiwum Medycyny Wewnetrznej, 1976, Volume: 55, Issue:3 Topics: Angiotensin II; Contraceptives, Oral; Feedback; Female; Fetus; Hemolytic-Uremic Syndrome; Humans; Hypertension; Liver; Myocardial Infarction; Pregnancy; Vitamin A	1976
Cardioprotection and ACE inhibitors. Clinical physiology and biochemistry, 1992, Volume: 9, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Prognosis	1992
Importance of RAA system and the treatment of patients with ACE inhibition after myocardial infarction. Angiology, 1991, Volume: 42, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Heart Arrest; Humans; Myocardial Infarction; Myocardium; Oxygen Consumption; Renin-Angiotensin System	1991
Issues surrounding a local cardiac renin system and the beneficial actions of angiotensin-converting enzyme inhibitors in ischemic myocardium. The American journal of cardiology, 1990, May-22, Volume: 65, Issue:19 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Dogs; Heart; In Vitro Techniques; Myocardial Contraction; Myocardial Infarction; Rats; Renin-Angiotensin System	1990
[Vasopressor drugs in shock due to myocardial infarction]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1967, Oct-02, Volume: 22, Issue:45 Topics: Angiotensin II; Epinephrine; Humans; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Vasoconstrictor Agents	1967
Pharmacologic assistance to the failing circulation. Surgery, gynecology & obstetrics, 1968, Volume: 126, Issue:3 Topics: Adenosine Triphosphatases; Aminophylline; Angiotensin II; Blood Gas Analysis; Blood Pressure; Cardiac Output; Chlorpromazine; Digitalis Glycosides; Heart Failure; Humans; Myocardial Infarction; Phenoxybenzamine; Pulmonary Edema; Shock, Hemorrhagic; Shock, Septic; Sympatholytics; Sympathomimetics; Vascular Resistance; Water-Electrolyte Balance	1968
The cardiovascular effects of oral contraceptives. Modern concepts of cardiovascular disease, 1972, Volume: 41, Issue:8 Topics: Aldosterone; Angiotensin II; Blood Coagulation; Blood Flow Velocity; Blood Vessels; Cardiovascular System; Cerebrovascular Disorders; Contraceptives, Oral; Estrogens; Female; Humans; Hypertension; Migraine Disorders; Muscle, Smooth; Myocardial Infarction; Platelet Adhesiveness; Pregnancy; Pulmonary Embolism; Renin; Thromboembolism; Thrombosis; Varicose Veins; Veins	1972

Trials

17 trial(s) available for angiotensin ii and Cardiovascular Stroke

Article	Year
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England journal of medicine, 2003, Jan-30, Volume: 348, Issue:5 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskrift for laeger, 2003, Jun-23, Volume: 165, Issue:26 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. American heart journal, 2004, Volume: 147, Issue:3 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Electrocardiography; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left	2004
[Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency]. Kardiologiia, 1993, Volume: 33, Issue:12 Topics: Adult; Aged; Angiotensin II; Baroreflex; Captopril; Cardiac Output, Low; Chronic Disease; Digoxin; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Norepinephrine; Sclerosis; Stroke Volume; Time Factors	1993
Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study). The American journal of cardiology, 1994, Jun-15, Volume: 73, Issue:16 Topics: Aged; Angiotensin II; Blood Pressure; Captopril; Cardiac Volume; Cause of Death; Double-Blind Method; Drug Tolerance; Enalapril; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Stroke Volume; Survival Rate; Ventricular Function, Left	1994
[Treatment of acute myocardial infarction with oral captopril. A randomized, double blind and placebo controlled pilot study]. Zhonghua xin xue guan bing za zhi, 1993, Volume: 21, Issue:2 Topics: Angiotensin II; Blood Pressure; Captopril; Double-Blind Method; Humans; Myocardial Infarction	1993
Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling. European heart journal, 1993, Volume: 14, Issue:8 Topics: Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Dopamine; Double-Blind Method; Enalapril; Epinephrine; Female; Hormones; Humans; Male; Myocardial Infarction; Norepinephrine; Peptidyl-Dipeptidase A; Survival Rate; Sweden; Ventricular Function, Left	1993
Early treatment with captopril after acute myocardial infarction. British heart journal, 1993, Volume: 69, Issue:3 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Captopril; Double-Blind Method; Drug Administration Schedule; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Vascular Resistance	1993
Effects of enalapril on ventricular volumes and neurohumoral status after inferior wall myocardial infarction. The American journal of the medical sciences, 1993, Volume: 305, Issue:4 Topics: Aged; Aldosterone; Angiotensin II; Cardiac Volume; Double-Blind Method; Enalapril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ventricular Function, Left	1993
Role of the fibrinolytic system in preventing myocardial infarction. European heart journal, 1995, Volume: 16 Suppl K Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Fibrinolysis; Humans; Myocardial Infarction; Renin-Angiotensin System	1995
Captopril plus losartan in early post-infarction. Neurohormonal effects: a pilot study. Giornale italiano di cardiologia, 1997, Volume: 27, Issue:12 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Pilot Projects; Single-Blind Method; Time Factors	1997
[Effect of puerarin on plasma endothelin, renin activity and angiotensin II in patients with acute myocardial infarction]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1997, Volume: 17, Issue:6 Topics: Aged; Angiotensin II; Endothelins; Female; Humans; Isoflavones; Male; Middle Aged; Myocardial Infarction; Renin; Renin-Angiotensin System; Vasodilator Agents	1997
Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study. Heart (British Cardiac Society), 1999, Volume: 81, Issue:6 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Pilot Projects; Single-Blind Method	1999
Angiotensin-converting enzyme inhibition restores hepatocyte growth factor production in patients with congestive heart failure. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:6 Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Heart Failure; Heparin; Hepatocyte Growth Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction	1999
Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction. American heart journal, 2001, Volume: 142, Issue:6 Topics: Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Catecholamines; Dopamine; Double-Blind Method; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Norepinephrine; Ramipril; Stroke Volume; Ventricular Remodeling	2001
[Development of heart failure after myocardial infarct: changes in plasma renin activity, angiotensin II, catecholamines and atrial natriuretic peptide]. Zeitschrift fur Kardiologie, 1991, Volume: 80 Suppl 8 Topics: Angiotensin II; Atrial Natriuretic Factor; Captopril; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Renin; Ventricular Function, Left	1991
[Use of hypertensin in the treatment of shock in myocardial infarct]. Hospital (Rio de Janeiro, Brazil), 1965, Volume: 68, Issue:3 Topics: Adult; Aged; Angiotensin II; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardial Infarction; Shock	1965

Other Studies

329 other study(ies) available for angiotensin ii and Cardiovascular Stroke

Article	Year
Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy. Oxidative medicine and cellular longevity, 2021, Volume: 2021 Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Cardiomyopathies; Cells, Cultured; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Protective Agents; Rats	2021
CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells. Circulation, 2022, 03-08, Volume: 145, Issue:10 Topics: Angiotensin II; Animals; Chemokine CCL17; Diphtheria Toxin; Heart Failure; Humans; Inflammation; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Phenylephrine; T-Lymphocytes, Regulatory; Ventricular Remodeling	2022
Fibroblast growth factor 12 attenuated cardiac remodeling via suppressing oxidative stress. Peptides, 2022, Volume: 153 Topics: Angiotensin II; Animals; Collagen; Fibroblast Growth Factors; Fibronectins; Fibrosis; Heart Failure; Mice; Myocardial Infarction; Myocardium; Oxidative Stress; Ventricular Remodeling	2022
Ginkgolide A alleviates cardiac remodeling in mice with myocardial infarction via binding to matrix metalloproteinase-9 to attenuate inflammation. European journal of pharmacology, 2022, May-15, Volume: 923 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Fibronectins; Fibrosis; Ginkgolides; Heart Diseases; Inflammation; Lactones; Matrix Metalloproteinase 9; Mice; Myocardial Infarction; Myocytes, Cardiac; Rats; Ventricular Remodeling	2022
MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3. Cardiovascular drugs and therapy, 2023, Volume: 37, Issue:4 Topics: Angiotensin II; Animals; Collagen; Fibrosis; Heart Failure; MAP Kinase Kinase Kinase 3; Mice; MicroRNAs; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Transforming Growth Factor beta1	2023
Angiotensin II inhibition increases diuresis during acute sympathetic activation in intact and denervated kidneys in rats with chronic myocardial infarction. Heart and vessels, 2022, Volume: 37, Issue:9 Topics: Angiotensin II; Animals; Blood Pressure; Diuresis; Kidney; Myocardial Infarction; Rats; Rats, Inbred WKY; Sympathetic Nervous System; Telmisartan	2022
Vaspin Ameliorates Cardiac Remodeling by Suppressing Phosphoinositide 3-Kinase/Protein Kinase B Pathway to Improve Oxidative Stress in Heart Failure Rats. Journal of cardiovascular pharmacology, 2022, 09-01, Volume: 80, Issue:3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Collagen; Fibrosis; Heart Failure; Myocardial Infarction; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Ventricular Remodeling	2022
Consequences of PDGFRα eLife, 2022, 09-23, Volume: 11 Topics: Angiotensin II; Animals; Calcium; Collagen; Fibroblasts; Fibrosis; Mice; Myocardial Infarction; Myocardium; Phenylephrine; Proteome; Receptor, Platelet-Derived Growth Factor alpha	2022
miR-409-3p Regulated by GATA2 Promotes Cardiac Fibrosis through Targeting Gpd1. Oxidative medicine and cellular longevity, 2022, Volume: 2022 Topics: Angiotensin II; Animals; Antagomirs; Fibrosis; GATA2 Transcription Factor; Mice; MicroRNAs; Myocardial Infarction; Myocardium; Rats; RNA, Small Interfering; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factors	2022
MicroRNA-19 upregulation attenuates cardiac fibrosis via targeting connective tissue growth factor. The American journal of the medical sciences, 2023, Volume: 365, Issue:4 Topics: Angiotensin II; Animals; Connective Tissue Growth Factor; Fibroblasts; Fibrosis; Heart Failure; MicroRNAs; Myocardial Infarction; Myocardium; Rats; Transforming Growth Factor beta1; Up-Regulation	2023
Discovery of 14-3-3 zeta as a potential biomarker for cardiac hypertrophy. BMB reports, 2023, Volume: 56, Issue:6 Topics: 14-3-3 Proteins; Angiotensin II; Biomarkers; Cardiomegaly; Humans; Myocardial Infarction; Myocytes, Cardiac; Proteomics	2023
Aloe-emodin ameliorated MI-induced cardiac remodeling in mice via inhibiting TGF-β/SMAD signaling via up-regulating SMAD7. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 114 Topics: Aloe; Angiotensin II; Animals; Cardiomyopathies; Emodin; Fibrosis; Hypertrophy; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; Signal Transduction; Smad7 Protein; Transforming Growth Factor beta1; Ventricular Remodeling	2023
Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats. Bioscience reports, 2019, 12-20, Volume: 39, Issue:12 Topics: Angiotensin II; Animals; Animals, Newborn; Antagomirs; Atrial Remodeling; Disease Models, Animal; Heart; Heart Failure; Humans; MicroRNAs; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling	2019
Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:1 Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Disease Models, Animal; Injections, Intraperitoneal; Janus Kinase 2; Losartan; Male; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; STAT3 Transcription Factor	2020
Phosphorylation of GATA4 at serine 105 is required for left ventricular remodelling process in angiotensin II-induced hypertension in rats. Basic & clinical pharmacology & toxicology, 2020, Volume: 127, Issue:3 Topics: Angiotensin II; Animals; Apoptosis; Cell Proliferation; Echocardiography; Fibroblasts; Fibrosis; GATA4 Transcription Factor; Hypertension; Male; Myocardial Infarction; Myocytes, Cardiac; Phosphorylation; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Ventricular Remodeling	2020
Hyperlipidemia inhibits the protective effect of lisinopril after myocardial infarction via activation of dendritic cells. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Dendritic Cells; Disease Models, Animal; Heart; Humans; Hyperlipidemias; Lipoproteins, LDL; Lisinopril; Mice; Mice, Knockout; Myeloid Differentiation Factor 88; Myocardial Infarction; Myocardium; NF-kappa B; Signal Transduction; Toll-Like Receptor 4; Ventricular Remodeling	2020
Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1. Cardiovascular research, 2021, 01-01, Volume: 117, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Disease Models, Animal; Endothelial Cells; Heart Failure; Leukocyte Rolling; Macrophages; Male; Mice, Inbred C57BL; Monocytes; Muramidase; Myeloid Cells; Myocardial Infarction; NADPH Oxidase 2; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Vasculitis	2021
Apelin-13 alleviated cardiac fibrosis via inhibiting the PI3K/Akt pathway to attenuate oxidative stress in rats with myocardial infarction-induced heart failure. Bioscience reports, 2020, 04-30, Volume: 40, Issue:4 Topics: Angiotensin II; Animals; Disease Models, Animal; Echocardiography; Fibroblasts; Fibrosis; Heart; Heart Failure; Humans; Injections, Intraperitoneal; Intercellular Signaling Peptides and Proteins; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction	2020
Increase in PKCα Activity during Heart Failure Despite the Stimulation of PKCα Braking Mechanism. International journal of molecular sciences, 2020, Apr-07, Volume: 21, Issue:7 Topics: Angiotensin II; Diastole; Diglycerides; Heart; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C-alpha; Quality of Life; Signal Transduction	2020
Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice. Skeletal muscle, 2020, 04-25, Volume: 10, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Fibrosis; Lisinopril; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; Myocardial Infarction; Smad Proteins; Transforming Growth Factor beta	2020
Targeting JMJD3 histone demethylase mediates cardiac fibrosis and cardiac function following myocardial infarction. Biochemical and biophysical research communications, 2020, 08-06, Volume: 528, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Enzyme Inhibitors; Extracellular Matrix; Fibroblasts; Heart; Jumonji Domain-Containing Histone Demethylases; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium	2020
Nitroxide-enhanced MRI of cardiovascular oxidative stress. NMR in biomedicine, 2020, Volume: 33, Issue:9 Topics: Adenosine; Angiotensin II; Animals; Cardiovascular System; Cyclic N-Oxides; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Myocardial Infarction; Nitrogen Oxides; Obesity; Oxidative Stress; Perfusion; Pyrrolidines	2020
MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats. Bioscience reports, 2020, 09-30, Volume: 40, Issue:9 Topics: Angiotensin II; Animals; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Echocardiography; Fibroblasts; Fibrosis; Heart; Heart Failure; Humans; Male; MicroRNAs; Myocardial Infarction; Myocardium; Primary Cell Culture; Rats; Signal Transduction	2020
Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin ii type i receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry - National Institute of Cardiology journal, 2021, Volume: 28, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Vessels; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Registries; Republic of Korea	2021
Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish. PloS one, 2020, Volume: 15, Issue:10 Topics: Adult; Amino Acid Substitution; Angiotensin II; Animals; Animals, Genetically Modified; Cardiomyopathy, Hypertrophic, Familial; Child; Chlorocebus aethiops; Connexin 43; Connexins; COS Cells; Disease Models, Animal; DNA Mutational Analysis; Doxorubicin; Female; Gap Junctions; Gene Knockout Techniques; Genetic Testing; Heart Transplantation; Humans; Induced Pluripotent Stem Cells; Male; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Pedigree; Primary Cell Culture; Protein Domains; Rats; Zebrafish; Zebrafish Proteins	2020
Renin-angiotensin system overactivation in perivascular adipose tissue contributes to vascular dysfunction in heart failure. Clinical science (London, England : 1979), 2020, 12-11, Volume: 134, Issue:23 Topics: Adipose Tissue; Angiotensin II; Animals; Aorta, Thoracic; Biological Availability; Endothelium, Vascular; Heart Failure; Hemodynamics; Male; Models, Biological; Myocardial Infarction; Nitric Oxide; Oxidative Stress; Peptidyl-Dipeptidase A; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Vasoconstriction	2020
Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction. Journal of cardiovascular pharmacology, 2021, 02-01, Volume: 77, Issue:2 Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Gallic Acid; Male; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling	2021
Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin. Circulation research, 2021, 05-28, Volume: 128, Issue:11 Topics: Angiotensin II; Animals; Antifibrotic Agents; Cardiomegaly; Cell Survival; Disease Models, Animal; Extracellular Matrix; Fibrosis; Gene Expression; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myofibroblasts; NIH 3T3 Cells; p38 Mitogen-Activated Protein Kinases; Pyrans; rho-Associated Kinases; Ventricular Remodeling	2021
Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats. Amino acids, 2021, Volume: 53, Issue:7 Topics: Angiotensin II; Animals; Fibrosis; Galanin-Like Peptide; Heart Failure; Male; Malondialdehyde; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Vasoconstrictor Agents	2021
The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling. Free radical biology & medicine, 2017, Volume: 108 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Disease Models, Animal; Fibronectins; Glutaredoxins; Heart; Humans; Male; Myocardial Infarction; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Oleanolic Acid; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Ventricular Remodeling	2017
The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction. Molecular medicine reports, 2017, Volume: 16, Issue:2 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Collagen; Fibrosis; Heart Function Tests; Immunohistochemistry; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling	2017
Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria. Clinical and experimental pharmacology & physiology, 2017, Volume: 44, Issue:12 Topics: Angiotensin II; Animals; Benzophenanthridines; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; MAP Kinase Signaling System; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Protein Kinase C-delta; Protein Kinase C-epsilon; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley	2017
Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction. Autonomic neuroscience : basic & clinical, 2017, Volume: 208 Topics: Angiotensin II; Animals; Biomarkers; Disease Models, Animal; Disease Progression; Dogs; Electric Stimulation Therapy; GAP-43 Protein; Heart; Heart Failure; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Growth Factor; Norepinephrine; Parasympathetic Nervous System; Proto-Oncogene Proteins c-fos; Random Allocation; Tyrosine 3-Monooxygenase	2017
Sex Differences in Vascular Reactivity to Angiotensin II During the Evolution of Myocardial Infarction. Journal of cardiovascular pharmacology, 2018, Volume: 71, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Disease Models, Animal; Female; Male; Myocardial Infarction; Rats, Wistar; Receptor, Angiotensin, Type 1; Sex Factors; Time Factors; Vasoconstriction; Vasoconstrictor Agents	2018
Cardiac and respiratory-gated volumetric murine ultrasound. The international journal of cardiovascular imaging, 2018, Volume: 34, Issue:5 Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Dissection; Biomechanical Phenomena; Cardiac-Gated Imaging Techniques; Disease Models, Animal; Echocardiography, Four-Dimensional; Heart Ventricles; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; Myocardial Infarction; Predictive Value of Tests; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Vascular Stiffness; Ventricular Function, Left	2018
Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 45, Issue:4 Topics: Actins; Angiotensin II; Animals; Base Sequence; Caveolin 3; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Disease Models, Animal; Down-Regulation; Fibroblasts; Fibrosis; Male; Mice; MicroRNAs; Myocardial Infarction; Myocardium; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; RNA Interference	2018
Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction. Scientific reports, 2018, 03-15, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; GATA4 Transcription Factor; Gene Expression Regulation; Homeobox Protein Nkx-2.5; Hypertension; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Phosphorylation; Protein Interaction Domains and Motifs; Rats, Sprague-Dawley; Reperfusion Injury; Small Molecule Libraries	2018
Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression. International journal of medical sciences, 2018, Volume: 15, Issue:5 Topics: Angiotensin II; Animals; Atorvastatin; Coronary Vessels; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Rats; Uncoupling Protein 2	2018
MicroRNA 199a-5p induces apoptosis by targeting JunB. Scientific reports, 2018, 04-27, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; Cell Line; Disease Models, Animal; Gene Expression Regulation; Heart Failure; MicroRNAs; Myocardial Infarction; Myocytes, Cardiac; Rats	2018
Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca Cell death & disease, 2018, 05-23, Volume: 9, Issue:6 Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Endoplasmic Reticulum; Fibroblasts; Fibrosis; Heart Function Tests; Mice, Knockout; Models, Biological; Myocardial Infarction; Myocardium; Nogo Proteins; Rats; SEC Translocation Channels; Transforming Growth Factor beta1; Up-Regulation	2018
Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling. Biological & pharmaceutical bulletin, 2018, Volume: 41, Issue:8 Topics: Albuminuria; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cardio-Renal Syndrome; Creatinine; Cystatin C; Drugs, Chinese Herbal; Interleukin-6; Kidney; Male; Myocardial Infarction; NADPH Oxidase 2; Natriuretic Peptide, Brain; Oxidative Stress; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Signal Transduction; Tumor Necrosis Factor-alpha	2018
Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy. Molecular medicine reports, 2018, Volume: 18, Issue:4 Topics: Angiotensin II; Animals; Cardiomegaly; Cell Line; Chalcone; Disease Models, Animal; Heme Oxygenase-1; Male; Myocardial Infarction; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Protective Agents; Quinones; Rats; Rats, Sprague-Dawley; Signal Transduction	2018
Clinical significance of increased urotensin II levels in acute myocardial infarction. Discovery medicine, 2018, Volume: 26, Issue:141 Topics: Angiotensin II; Animals; Animals, Newborn; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Phosphorylation; Predictive Value of Tests; Rats, Wistar; Sensitivity and Specificity; Stroke Volume; Up-Regulation; Urotensins	2018
Increase of chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes after acute myocardial infarction chymase activity after acute myocardial infarction. Heart and vessels, 2019, Volume: 34, Issue:7 Topics: Aged; Angiotensin II; Cathepsin G; Chymases; Cross-Sectional Studies; Female; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Myocardium; Percutaneous Coronary Intervention	2019
Epigenetic modulation of tenascin C in the heart: implications on myocardial ischemia, hypertrophy and metabolism. Journal of hypertension, 2019, Volume: 37, Issue:9 Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; DNA Methylation; Energy Metabolism; Epigenesis, Genetic; Extracellular Matrix; Extracellular Matrix Proteins; Fibrosis; Heart Diseases; Humans; Hypertrophy; Hypoxia; Male; Matrix Metalloproteinase 2; MicroRNAs; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Rats; Tenascin; Ventricular Remodeling	2019
The role and mechanism of transforming growth factor beta 3 in human myocardial infarction-induced myocardial fibrosis. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:6 Topics: Adult; Aged; Angiotensin II; Cell Movement; Cell Proliferation; Collagen; Fibroblasts; Fibrosis; Humans; Middle Aged; Myocardial Infarction; Myocardium; Phosphorylation; Signal Transduction; Smad7 Protein; Transforming Growth Factor beta3; Up-Regulation	2019
Spermidine-enhanced autophagic flux improves cardiac dysfunction following myocardial infarction by targeting the AMPK/mTOR signalling pathway. British journal of pharmacology, 2019, Volume: 176, Issue:17 Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Apoptosis; Cardiotonic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Male; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; Spermidine; Structure-Activity Relationship; TOR Serine-Threonine Kinases	2019
Renal Sympathetic Denervation Improves Outcomes in a Canine Myocardial Infarction Model. Medical science monitor : international medical journal of experimental and clinical research, 2019, May-25, Volume: 25 Topics: Angiotensin II; Animals; Blood Pressure; Denervation; Disease Models, Animal; Dogs; Echocardiography; Female; Heart; Heart Failure; Kidney; Male; Myocardial Infarction; Myocardium; Renal Artery; Renin-Angiotensin System; Sympathectomy; Sympathetic Nervous System; Ventricular Function, Left	2019
TSLP promote M2 macrophages polarization and cardiac healing after myocardial infarction. Biochemical and biophysical research communications, 2019, 08-20, Volume: 516, Issue:2 Topics: Angiotensin II; Animals; Cell Polarity; Cytokines; Female; Heart Function Tests; Inflammation; Macrophage Activation; Macrophages; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Phenotype; Thymic Stromal Lymphopoietin; Wound Healing	2019
Xin-Ji-Er-Kang ameliorates kidney injury following myocardial infarction by inhibiting oxidative stress via Nrf2/HO-1 pathway in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 117 Topics: Angiotensin II; Animals; Blood Urea Nitrogen; Cystatin C; DNA Damage; Down-Regulation; Drugs, Chinese Herbal; Heme Oxygenase-1; Hemodynamics; Kidney; Myocardial Infarction; NADPH Oxidase 4; NF-E2-Related Factor 2; Organ Size; Oxidative Stress; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction	2019
Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction. JCI insight, 2019, 07-09, Volume: 5 Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Cardiomyopathies; Cell Survival; Cicatrix; Echocardiography; Fibrosis; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Inflammation; Macrophages; Membrane Glycoproteins; Mice; Monocytes; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Regeneration; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Remodeling	2019
Protocatechuic acid attenuates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the NOX4/ROS/p38 signaling pathway. Phytotherapy research : PTR, 2019, Volume: 33, Issue:9 Topics: Angiotensin II; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Fibrosis; Hydroxybenzoates; Myocardial Infarction; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Signal Transduction	2019
Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling. Clinical science (London, England : 1979), 2014, Volume: 126, Issue:4 Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Hypertension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Signal Transduction; Transforming Growth Factor beta; Vasoconstrictor Agents	2014
Dynamic remodeling of the guinea pig intrinsic cardiac plexus induced by chronic myocardial infarction. Autonomic neuroscience : basic & clinical, 2014, Volume: 181 Topics: Angiotensin II; Animals; Axons; Bethanechol; Chronic Disease; Guinea Pigs; Heart; In Vitro Techniques; Male; Membrane Potentials; Myocardial Infarction; Neurons; Nitric Oxide Synthase Type I; Norepinephrine; Parasympathomimetics; Sympathetic Nervous System; Sympathomimetics; Synaptic Transmission; Time Factors; Vasoconstrictor Agents	2014
Enhanced cardioprotective effects mediated by plasmid containing the short-hairpin RNA of angiotensin converting enzyme with a biodegradable hydrogel after myocardial infarction. Journal of biomedical materials research. Part A, 2014, Volume: 102, Issue:10 Topics: Angiotensin II; Animals; Apoptosis; Biocompatible Materials; Cardiotonic Agents; Green Fluorescent Proteins; Hemodynamics; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Myocardial Infarction; Myocytes, Cardiac; Peptidyl-Dipeptidase A; Phase Transition; Plasmids; Rats, Wistar; RNA, Messenger; RNA, Small Interfering; Temperature; Ultrasonography	2014
Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair. PloS one, 2013, Volume: 8, Issue:12 Topics: Angiotensin II; Animals; Apoptosis; Bone Marrow Cells; Cell Transplantation; Coculture Techniques; Echocardiography; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Inflammation; Leukocytes, Mononuclear; Male; Myocardial Infarction; Myocytes, Cardiac; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Stem Cell Transplantation; Tetrazoles; Valine; Valsartan; Vascular Endothelial Growth Factor A	2013
Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2014, Apr-01, Volume: 306, Issue:7 Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Enzyme Inhibitors; Glutamyl Aminopeptidase; Kinetics; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Tandem Mass Spectrometry; Ventricular Remodeling	2014
Cryptotanshinone attenuates cardiac fibrosis via downregulation of COX-2, NOX-2, and NOX-4. Journal of cardiovascular pharmacology, 2014, Volume: 64, Issue:1 Topics: Angiotensin II; Animals; Cells, Cultured; Cyclooxygenase 2; Down-Regulation; Fibroblasts; Fibrosis; Male; Membrane Glycoproteins; Myocardial Infarction; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Phenanthrenes; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Up-Regulation	2014
Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53. British journal of pharmacology, 2014, Volume: 171, Issue:15 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Cells, Cultured; Fibroblasts; Growth Differentiation Factor 15; Heart Rupture; Hypoxia; Imidazoles; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Peroxidase; Tetrazoles; Tumor Suppressor Protein p53	2014
A comparison of the efficacy of surgical renal denervation and pharmacologic therapies in post-myocardial infarction heart failure. PloS one, 2014, Volume: 9, Issue:5 Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Denervation; Disease Models, Animal; Endothelins; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Norepinephrine; Rats; Rats, Wistar; Renin; Treatment Outcome; Ventricular Function, Left	2014
Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat. Journal of cellular physiology, 2015, Volume: 230, Issue:1 Topics: Actins; Airway Remodeling; Angiotensin II; Animals; Biomarkers; Cell Differentiation; Collagen Type I; Diabetes Mellitus, Type 1; Fibroblasts; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; MicroRNAs; Myocardial Contraction; Myocardial Infarction; Nestin; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Transforming Growth Factor beta	2015
Effects of acute angiotensin II on ischemia reperfusion injury following myocardial infarction. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:1 Topics: Angiotensin II; Animals; Animals, Newborn; Body Weight; Cell Survival; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Rats, Wistar; Ultrasonography; Ventricular Remodeling	2015
Ang (1-7) is a modulator of the vasoconstrictor actions of Ang I and Ang II. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Aorta; In Vitro Techniques; Male; Myocardial Infarction; Myocardium; Peptide Fragments; Rats, Wistar; Vasoconstrictor Agents	2015
Activation of NADPH oxidase mediates increased endoplasmic reticulum stress and left ventricular remodeling after myocardial infarction in rabbits. Biochimica et biophysica acta, 2015, Volume: 1852, Issue:5 Topics: Acetophenones; Angiotensin II; Animals; Apoptosis; Blotting, Western; Cell Line; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heat-Shock Proteins; Microscopy, Confocal; Myocardial Infarction; Myocytes, Cardiac; NADPH Oxidases; Rabbits; Random Allocation; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Survival Rate; Transcription Factor CHOP; Vasoconstrictor Agents; Ventricular Remodeling	2015
Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction. Journal of cellular and molecular medicine, 2015, Volume: 19, Issue:8 Topics: Angiotensin II; Animals; Blood Vessels; Cardiotonic Agents; Collagen; Fibrosis; Heart Function Tests; Hemodynamics; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ultrasonography; Valsartan	2015
Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. International journal of cardiology, 2015, Jun-01, Volume: 188 Topics: Analysis of Variance; Angiotensin II; Animals; Biopsy, Needle; Blotting, Western; Cell Survival; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Echocardiography; Female; Gap Junctions; Immunohistochemistry; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Transplantation Conditioning; Treatment Outcome; Vascular Endothelial Growth Factor A	2015
Angiotensin receptors alter myocardial infarction-induced remodeling of the guinea pig cardiac plexus. American journal of physiology. Regulatory, integrative and comparative physiology, 2015, Jul-15, Volume: 309, Issue:2 Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Disease Models, Animal; Electric Stimulation; Evoked Potentials; Guinea Pigs; Heart; Male; Myocardial Infarction; Norepinephrine; Presynaptic Terminals; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Presynaptic; Signal Transduction; Time Factors	2015
Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring. Biology of reproduction, 2015, Volume: 93, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Diet, High-Fat; Female; Fetal Development; Genetic Predisposition to Disease; Heart Diseases; Imidazoles; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sex Characteristics	2015
Cardiac stem cells transplantation enhances the expression of connexin 43 via the ANG II/AT1R/TGF-beta1 signaling pathway in a rat model of myocardial infarction. Experimental and molecular pathology, 2015, Volume: 99, Issue:3 Topics: Angiotensin II; Animals; Connexin 43; Disease Models, Animal; Male; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Stem Cell Transplantation; Transforming Growth Factor beta1	2015
Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression. The Journal of thoracic and cardiovascular surgery, 2016, Volume: 151, Issue:4 Topics: Angiotensin II; Animals; Calcium; Cardiomyopathies; Collagen; Disease Models, Animal; Enzyme Induction; Fibronectins; Fibrosis; Genetic Therapy; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Myocardium; Myofibroblasts; Receptor, Angiotensin, Type 1; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sheep; Time Factors; Transforming Growth Factor beta	2016
Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:5 Topics: Angiotensin II; Animals; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Genetic Predisposition to Disease; Heredity; Hyperlipoproteinemia Type II; Infusion Pumps, Implantable; Infusions, Subcutaneous; Myocardial Infarction; Phenotype; Plaque, Atherosclerotic; Rabbits; Time Factors	2016
Histamine H3 Receptor Agonist Imetit Attenuated Isoproterenol Induced Renin Angiotensin System and Sympathetic Nervous System Overactivity in Myocardial Infarction of Rats. Drug research, 2016, Volume: 66, Issue:6 Topics: Angiotensin II; Animals; Antioxidants; Cardiotonic Agents; Histamine Agonists; Histamine H3 Antagonists; Imidazoles; Isoproterenol; Losartan; Male; Myocardial Infarction; Myocardium; Norepinephrine; Piperidines; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Thiourea	2016
Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug design, development and therapy, 2016, Volume: 10 Topics: Angiotensin II; Animals; Cells, Cultured; Curcumin; Enzyme Activation; Fibroblasts; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Sirtuin 1; Structure-Activity Relationship	2016
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo. Journal of cellular and molecular medicine, 2016, Volume: 20, Issue:11 Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1	2016
MicroRNA-214 exerts a Cardio-protective effect by inhibition of fibrosis. Anatomical record (Hoboken, N.J. : 2007), 2016, Volume: 299, Issue:10 Topics: Angiotensin II; Animals; Collagen Type I; Collagen Type III; Disease Models, Animal; Fibroblasts; Fibrosis; Heart; Male; MicroRNAs; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Transfection; Transforming Growth Factor beta1	2016
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin. Oncotarget, 2016, Oct-04, Volume: 7, Issue:40 Topics: Angiotensin II; Animals; beta Catenin; Cells, Cultured; Collagen; Dependovirus; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibrosis; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 4; Reperfusion Injury; RNA, Small Interfering; Transforming Growth Factor beta; Up-Regulation	2016
Angiotensin II increases coronary fibrosis, cardiac hypertrophy and the incidence of myocardial infarctions in ApoE Acta cardiologica, 2016, Volume: 71, Issue:4 Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Fibrillin-1; Mice; Myocardial Infarction; Myocardium; Organ Size; Peptide Fragments; Treatment Outcome	2016
LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:17 Topics: Angiotensin II; Animals; Cardiomegaly; Mice; MicroRNAs; Myocardial Infarction; Myocytes, Cardiac; Rats; RNA, Long Noncoding	2016
Transcription factor PEX1 modulates extracellular matrix turnover through regulation of MMP-9 expression. Cell and tissue research, 2017, Volume: 367, Issue:2 Topics: Adenoviridae; Aging; Angiotensin II; Animals; Animals, Newborn; Base Sequence; Extracellular Matrix; Fibroblasts; Fibrosis; Gene Expression Regulation; Gene Silencing; Gene Transfer Techniques; Hypertension; Matrix Metalloproteinase 9; Membrane Proteins; Models, Biological; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Promoter Regions, Genetic; Rats, Sprague-Dawley; Transcription Factors	2017
Angiotensin-(1-9): New Promise for Post-Infarct Functional Therapy. Journal of the American College of Cardiology, 2016, 12-20, Volume: 68, Issue:24 Topics: Angiotensin II; Humans; Myocardial Infarction	2016
MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 40, Issue:6 Topics: Angiotensin II; Animals; Base Sequence; Cells, Cultured; Collagen; Down-Regulation; Fibroblasts; Fibrosis; Gene Silencing; Male; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardium; Protein Serine-Threonine Kinases; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta	2016
Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II. Molecules (Basel, Switzerland), 2016, Dec-28, Volume: 22, Issue:1 Topics: Angiotensin II; Animals; Antioxidants; Catalase; Disease Models, Animal; Fenofibrate; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Myocardial Infarction; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Superoxide Dismutase; Superoxide Dismutase-1; Triglycerides	2016
Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis. Scientific reports, 2017, 01-16, Volume: 7 Topics: Angiotensin II; Animals; Cardiomegaly; Collagen Type I; Collagen Type III; Feedback, Physiological; Fibrosis; Hemodynamics; Hydroxyproline; Liver X Receptors; Male; Myocardial Infarction; Myocardium; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridones; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Systole; Ventricular Dysfunction	2017
Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction. British journal of pharmacology, 2017, Volume: 174, Issue:10 Topics: Angiotensin II; Animals; Coronary Vessels; Ligation; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Serine Endopeptidases	2017
A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction. Scientific reports, 2017, 03-07, Volume: 7 Topics: Angiotensin II; Animals; Disease Models, Animal; Heart Failure; Myocardial Infarction; Rats; Treatment Outcome; Vaccines, Subunit; Vasoconstrictor Agents	2017
Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: relevance to stress and interaction with vasopressin. Stress (Amsterdam, Netherlands), 2008, Volume: 11, Issue:4 Topics: Angiotensin II; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Heart Rate; Injections, Intraventricular; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Stress, Physiological; Vasopressins	2008
Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats. European journal of pharmacology, 2009, Jan-05, Volume: 602, Issue:1 Topics: Angiotensin II; Animals; Collagen; Male; Myocardial Infarction; Natriuretic Agents; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; RNA, Messenger; Smad2 Protein; Time Factors; Transforming Growth Factor beta1; Treatment Outcome; Ventricular Remodeling	2009
[Mechanisms of losartan for inhibition of myocardial fibrosis following myocardial infarction in rats]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:12 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Fibrosis; Losartan; Male; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; RNA, Messenger	2008
Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats. Pflugers Archiv : European journal of physiology, 2009, Volume: 458, Issue:2 Topics: Angiotensin II; Animals; Cyclic N-Oxides; Male; Medulla Oblongata; Myocardial Infarction; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxides; Sympathetic Nervous System; Ventricular Dysfunction	2009
Central TNF-alpha elevates blood pressure and sensitizes to central pressor action of angiotensin II in the infarcted rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008, Volume: 59 Suppl 8 Topics: Angiotensin II; Animals; Blood Pressure; Brain; Heart Failure; Heart Rate; Injections, Intraventricular; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tumor Necrosis Factor-alpha	2008
Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Binding Sites; Biomarkers; Disease Models, Animal; Feasibility Studies; Fluorescent Dyes; Heart Failure; Losartan; Male; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Microscopy, Fluorescence, Multiphoton; Microscopy, Video; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Receptors, Angiotensin; Technetium; Time Factors; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling; X-Ray Microtomography	2008
Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Benzazepines; Bradykinin; Cardiotonic Agents; Collagen; Coronary Circulation; Electrocardiography; Heart Rate; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Ivabradine; Male; Myocardial Infarction; Neovascularization, Physiologic; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ventricular Remodeling	2009
Effect of early versus late AT(1) receptor blockade with losartan on postmyocardial infarction ventricular remodeling in rabbits. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Collagen; Losartan; Lymphocytes; Macrophages; Muscle Cells; Myocardial Infarction; Myocardium; Neutrophil Infiltration; Organ Size; Rabbits; Receptor, Angiotensin, Type 1; Survival Analysis; Ventricular Remodeling	2009
Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure. Cardiovascular research, 2009, Sep-01, Volume: 83, Issue:4 Topics: Action Potentials; Angiotensin II; Animals; ATP-Binding Cassette Transporters; Cells, Cultured; Diazoxide; Forkhead Transcription Factors; Gene Expression; Heart Failure; KATP Channels; Myocardial Infarction; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; RNA, Messenger; Sulfonylurea Receptors; Tumor Necrosis Factor-alpha; Ventricular Remodeling	2009
Immunology. Dispensable but not irrelevant. Science (New York, N.Y.), 2009, Jul-31, Volume: 325, Issue:5940 Topics: Angiotensin II; Animals; Antigens, Ly; Mice; Monocytes; Myocardial Infarction; Myocardium; Receptors, CCR2; Receptors, Chemokine; Signal Transduction; Spleen; Ventricular Remodeling	2009
Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (New York, N.Y.), 2009, Jul-31, Volume: 325, Issue:5940 Topics: Angiotensin II; Animals; Antigens, Ly; Bone Marrow Cells; Cell Differentiation; Cell Movement; Cell Size; Female; Inflammation; Mice; Mice, Inbred C57BL; Monocytes; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Angiotensin; Spleen; Splenectomy	2009
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circulation. Heart failure, 2009, Volume: 2, Issue:5 Topics: Adaptation, Physiological; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Disease Models, Animal; Enzyme Activation; Inflammation Mediators; Irbesartan; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Receptor, Angiotensin, Type 1; RNA, Messenger; Superoxides; Tetrazoles; Time Factors; Ultrasonography; Ventricular Remodeling	2009
Upregulation of cardiac matrix Gla protein expression in response to hypertrophic stimuli. Blood pressure, 2009, Volume: 18, Issue:5 Topics: Angiotensin II; Animals; Animals, Newborn; Arginine Vasopressin; Calcium-Binding Proteins; Cells, Cultured; Endothelin-1; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Matrix Gla Protein; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA, Messenger; Stress, Mechanical; Up-Regulation	2009
Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Acta physiologica (Oxford, England), 2010, Volume: 199, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis Regulatory Proteins; Cells, Cultured; Cytokine TWEAK; Gene Expression; Inflammation; Losartan; Male; Membrane Proteins; Myocardial Infarction; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; RNA, Messenger; Signal Transduction; Stress, Mechanical; Tumor Necrosis Factors; TWEAK Receptor; Ventricular Remodeling	2010
Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction. Circulation. Heart failure, 2010, Volume: 3, Issue:2 Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Animals; Bone Marrow Cells; Heart Failure; Hemodynamics; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocytes, Cardiac; Peptide Fragments; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A	2010
A novel p38 MAPK target dyxin is rapidly induced by mechanical load in the heart. Blood pressure, 2010, Volume: 19, Issue:1 Topics: Adenoviridae; Angiotensin II; Animals; Carrier Proteins; Co-Repressor Proteins; Gene Transfer Techniques; Genetic Vectors; Heart; Heart Ventricles; Hypertension; In Vitro Techniques; LIM Domain Proteins; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Mechanical; Vasoconstrictor Agents; Ventricular Remodeling	2010
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. The Journal of clinical investigation, 2010, Volume: 120, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cell Degranulation; Chymases; Cricetinae; Mast Cells; Mesocricetus; Mice; Mice, Inbred C57BL; Microdialysis; Myocardial Infarction; Serine Endopeptidases; Ventricular Function, Left	2010
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro. Journal of hypertension, 2010, Volume: 28, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cardiomegaly; Cell Enlargement; Cells, Cultured; Enalapril; Humans; Hypertrophy, Left Ventricular; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Myocytes, Cardiac; Norepinephrine; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left	2010
Effects of Tongguan Capsule on post-myocardial infarction ventricular remodeling and cardiac function in rats. Chinese journal of integrative medicine, 2010, Volume: 16, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Capsules; Captopril; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Echocardiography, Doppler; Heart; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling	2010
ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Human gene therapy, 2010, Volume: 21, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Fibrosis; Gene Expression; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Inbred WKY; Ventricular Remodeling	2010
Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circulation research, 2010, Jul-23, Volume: 107, Issue:2 Topics: Amides; Angiotensin II; Animals; Base Sequence; Cell Transdifferentiation; Chlorocebus aethiops; Collagen; Collagen Type I; COS Cells; Disease Models, Animal; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Male; Mice; Mice, Knockout; Molecular Sequence Data; Myocardial Infarction; Myocardium; Myocytes, Smooth Muscle; Phenotype; Promoter Regions, Genetic; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Time Factors; Trans-Activators; Transcription, Genetic; Transfection; Transforming Growth Factor beta1; Ventricular Remodeling	2010
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010, Volume: 24, Issue:12 Topics: Amides; Angiotensin I; Angiotensin II; Animals; Apoptosis; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Fumarates; Heart; Kinins; Lung; Mice; Mice, Mutant Strains; Myocardial Infarction; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Renin; Reperfusion Injury	2010
Association of coronary inflammation and angiotensin II with impaired microvascular reperfusion in patients with ST-segment elevation myocardial infarction. International journal of cardiology, 2011, Jan-21, Volume: 146, Issue:2 Topics: Aged; Angiotensin II; Coronary Circulation; Electrocardiography; Female; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocarditis	2011
Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling. Die Pharmazie, 2010, Volume: 65, Issue:10 Topics: Angiotensin II; Animals; Collagen; Coronary Vessels; Hydroxyproline; Ligation; Male; Myocardial Infarction; Myocytes, Cardiac; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Scrophularia; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents; Ventricular Remodeling	2010
Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991. Cardiovascular therapeutics, 2012, Volume: 30, Issue:3 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Collagen; Disease Models, Animal; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Stroke Volume; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling	2012
Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats. Archives of cardiovascular diseases, 2011, Volume: 104, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Collagen; Cyclic GMP; Disease Models, Animal; Enalapril; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Phosphorylation; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA; Ventricular Function, Left; Ventricular Remodeling	2011
Improved cardiac function after sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia. Acta cardiologica, 2011, Volume: 66, Issue:1 Topics: Adenoviridae; Angiotensin II; Animals; Disease Models, Animal; Endothelin-1; Fluorescent Dyes; Gene Transfer Techniques; Genetic Therapy; Green Fluorescent Proteins; Heart Failure; Interleukin-6; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Stroke Volume; Swine; Swine, Miniature; Tumor Necrosis Factor-alpha	2011
Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circulation research, 2011, Jun-10, Volume: 108, Issue:12 Topics: Angiotensin II; Cell Differentiation; Coronary Artery Disease; Female; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Receptor, IGF Type 1; Receptor, IGF Type 2; Regeneration; Stem Cell Transplantation; Stem Cells; Transplantation, Autologous	2011
Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms. Circulation. Heart failure, 2011, Volume: 4, Issue:4 Topics: Adenoviridae; Angiotensin II; Animals; Collagen Type III; Disease Models, Animal; Fibrosis; Gene Transfer Techniques; Genetic Therapy; Humans; Hypertension; Ligation; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Neovascularization, Physiologic; Organothiophosphorus Compounds; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Dysfunction, Left; Ventricular Remodeling	2011
Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation. Biochemical and biophysical research communications, 2011, Jun-03, Volume: 409, Issue:2 Topics: Angiotensin II; Animals; Cells, Cultured; Coculture Techniques; Extracellular Matrix; Fibroblasts; Fibronectins; Male; Matrix Metalloproteinases; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Tenascin	2011
Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats. Pharmaceutical biology, 2011, Volume: 49, Issue:9 Topics: Angiotensin II; Animals; Antioxidants; Cardiotonic Agents; China; Creatine Kinase; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelins; Ginsenosides; Heart Ventricles; L-Lactate Dehydrogenase; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Panax; Phytotherapy; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley; Single-Blind Method; Superoxide Dismutase	2011
Brain AT1 receptor activates the sympathetic nervous system through toll-like receptor 4 in mice with heart failure. Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:5 Topics: Angiotensin II; Animals; Body Weight; Brain; Brain Stem; Electrocardiography; Heart; Heart Failure; Infusions, Intraventricular; Losartan; Male; Mice; Mice, Inbred ICR; Models, Biological; Myeloid Differentiation Factor 88; Myocardial Infarction; NF-kappa B; Norepinephrine; Organ Size; Receptor, Angiotensin, Type 1; Sympathetic Nervous System; Toll-Like Receptor 4; Ventricular Dysfunction, Left	2011
Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2012, Feb-15, Volume: 19, Issue:3-4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Chemical Analysis; Captopril; Cardiomegaly; Collagen; Coronary Vessels; Endothelin-1; Ethanol; Gene Expression Regulation; Hemodynamics; Hydroxyproline; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Plant Extracts; Plant Roots; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Scrophularia; Tumor Necrosis Factor-alpha; Ventricular Remodeling	2012
Influence of myocardial infarction on changes in the expression of angiotensin type 1 receptor in the rat prostate. Folia histochemica et cytobiologica, 2011, Volume: 49, Issue:3 Topics: Angiotensin II; Animals; Disease Models, Animal; Humans; Male; Myocardial Infarction; Prostate; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System	2011
Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction. Journal of molecular and cellular cardiology, 2012, Volume: 52, Issue:1 Topics: Angiotensin II; Animals; Calcium-Binding Proteins; Extracellular Matrix Proteins; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Signal Transduction; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Remodeling; Wound Healing	2012
p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction. Circulation research, 2012, Feb-17, Volume: 110, Issue:4 Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Binding Sites; Binding, Competitive; Cells, Cultured; Cyclic AMP Response Element Modulator; Diabetes Mellitus, Experimental; Enzyme Activation; MAP Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mitogen-Activated Protein Kinase 7; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Time Factors; Transfection; Ubiquitin-Protein Ligases	2012
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension. Clinical science (London, England : 1979), 2012, Volume: 122, Issue:11 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Benzoates; Blood Pressure; Cardiotonic Agents; Eicosanoids; Epoxide Hydrolases; Female; Hypertension; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Urea	2012
Time course of hydrogen peroxide-thioredoxin balance and its influence on the intracellular signalling in myocardial infarction. Experimental physiology, 2012, Volume: 97, Issue:6 Topics: Angiotensin II; Animals; Antioxidants; Apoptosis Regulatory Proteins; Glutathione Disulfide; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Failure; Hydrogen Peroxide; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Myocardial Infarction; Myocardium; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; Thioredoxins; TOR Serine-Threonine Kinases; Ventricular Remodeling	2012
The role of renin angiotensin system intervention in stage B heart failure. Heart failure clinics, 2012, Volume: 8, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Angiopathies; Heart Failure; Humans; Myocardial Infarction; Myocardial Ischemia; Renin-Angiotensin System; Signal Transduction; Stroke Volume; Ventricular Dysfunction, Left	2012
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts. Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:2 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Hemodynamics; Imidazoles; Lipid Peroxidation; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone; Tetrazoles; Ventricular Function, Left	2012
MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation, 2012, Aug-14, Volume: 126, Issue:7 Topics: Angiotensin II; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Chronic Disease; Collagen; Compliance; Echocardiography; Fibroblasts; Fibrosis; Gene Silencing; Hemodynamics; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardium; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Treatment Outcome; Vasoconstrictor Agents; Ventricular Dysfunction, Left	2012
Remodeling of intrinsic cardiac neurons: effects of β-adrenergic receptor blockade in guinea pig models of chronic heart disease. American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Nov-01, Volume: 303, Issue:9 Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Cholinergic Agents; Chronic Disease; Disease Models, Animal; Evoked Potentials; Guinea Pigs; Heart; Heart Diseases; Male; Myocardial Infarction; Neurons; Receptors, Adrenergic, beta; Timolol	2012
Preconditioning protects the heart in a prolonged uremic condition. American journal of physiology. Heart and circulatory physiology, 2012, Nov-15, Volume: 303, Issue:10 Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Urea; Uremia; Uric Acid; Ventricular Function, Left	2012
Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4. Free radical biology & medicine, 2013, Volume: 54 Topics: Angiotensin II; Animals; Cells, Cultured; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Gallic Acid; Leonurus; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction	2013
Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction. Molecular and cellular biochemistry, 2013, Volume: 376, Issue:1-2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Collagen; Male; Myocardial Infarction; Myocardial Reperfusion; Osteonectin; Pyridines; Rats, Sprague-Dawley; Secretory Leukocyte Peptidase Inhibitor; Tetrazoles; Thiazepines; Ventricular Remodeling	2013
Central AT1 receptors are involved in the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Basic research in cardiology, 2002, Volume: 97, Issue:4 Topics: Anesthetics, Local; Angiotensin II; Animals; Anti-Arrhythmia Agents; Bradykinin; Capsaicin; Heart Failure; Heart Ventricles; Hemodynamics; Injections, Intravenous; Injections, Intraventricular; Lidocaine; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Neurons, Afferent; Organ Size; Pericardium; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reflex; Renin; Sympathetic Nervous System; Ventricular Function	2002
Influence of angiotensin II type 1-receptor antagonist CV11974 on infarct size and adjacent regional function after ischemia-reperfusion in dogs. Japanese journal of pharmacology, 2002, Volume: 89, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Dogs; Hemodynamics; Myocardial Infarction; Receptors, Angiotensin; Reperfusion Injury; Tetrazoles; Ventricular Function, Left	2002
Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? Basic research in cardiology, 2002, Volume: 97, Issue:5 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin II; Biomarkers; Coronary Angiography; Coronary Circulation; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Ventricular Dysfunction, Left	2002
Exogenous angiotensin II does not facilitate norepinephrine release in the heart. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:4 Topics: Angiotensin II; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Female; Heart; Hemodynamics; Infusions, Intra-Arterial; Kinetics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Norepinephrine; Swine; Sympathetic Nervous System	2002
The role of locally expressed angiotensin converting enzyme in cardiac remodeling after myocardial infarction in mice. Cardiovascular research, 2002, Volume: 56, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Collagen; Hemodynamics; Kidney; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Ventricular Remodeling	2002
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation, 2002, Dec-03, Volume: 106, Issue:23 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Biomarkers; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Humans; Imidazoles; Interleukin-1; Interleukin-1 Receptor-Like 1 Protein; Interleukin-4; Lipopolysaccharides; Membrane Proteins; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Nuclease Protection Assays; Phorbol Esters; Promoter Regions, Genetic; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Receptors, Interleukin; Receptors, Interleukin-1; RNA, Messenger; Stress, Mechanical; Stroke Volume	2002
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovascular research, 2003, Volume: 57, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Collagen; Diastole; Drug Therapy, Combination; Echocardiography, Doppler; Imidazoles; Male; Models, Animal; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Thiazepines; Ventricular Remodeling	2003
The functional role of the JAK-STAT pathway in post-infarction remodeling. Cardiovascular research, 2003, Volume: 57, Issue:1 Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Apoptosis; DNA-Binding Proteins; Janus Kinase 1; Janus Kinase 2; Losartan; Milk Proteins; Models, Animal; Myocardial Infarction; Myocardium; Potassium Channels; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Time Factors; Trans-Activators; Tyrphostins; Ventricular Remodeling	2003
[Induction of left ventricular remodeling and dysfunction in the recipient heart following donor heart myocardial infarction: new insights into the pathological role of tumor necrosis factor-alpha from a novel heterotopic transplant-coronary ligation mode Journal of cardiology, 2003, Volume: 41, Issue:1 Topics: Angiotensin II; Animals; Heart Transplantation; Myocardial Infarction; Rats; Rats, Inbred Lew; Tissue Donors; Transplantation, Heterotopic; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling	2003
Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. Journal of molecular and cellular cardiology, 2003, Volume: 35, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Fibroblasts; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Pyridines; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2	2003
Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2003, Volume: 4, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bleeding Time; Captopril; Disease Models, Animal; Endothelium, Vascular; Female; Hemodynamics; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Vasodilation; Ventricular Fibrillation	2003
Expression and modulation of steroidogenic acute regulatory protein messenger ribonucleic acid in rat cardiocytes and after myocardial infarction. Endocrinology, 2003, Volume: 144, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Cells, Cultured; Dexamethasone; Gene Expression; Glucocorticoids; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocytes, Cardiac; Phosphoproteins; Rats; Rats, Wistar; RNA, Messenger	2003
[Biochemical remodeling of myocardial collagen and its relation to cardiac renin-angiotensin system in rats after myocardial infarction]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 2001, Volume: 32, Issue:1 Topics: Angiotensin II; Animals; Collagen; Male; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System	2001
Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene and angiotensin-II type 1 receptor gene polymorphisms in patients with coronary artery disease. Clinical chemistry and laboratory medicine, 2003, Volume: 41, Issue:4 Topics: Angiotensin II; Coronary Artery Disease; DNA; DNA Primers; Echocardiography; Female; Gene Deletion; Genotype; Homozygote; Humans; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Ventricular Function, Left; White People	2003
ANGIOTENSIN II IN THE TREATMENT OF SHOCK FOLLOWING MYOCARDIAL INFARCTION. The American journal of cardiology, 1964, Volume: 14 Topics: Angiotensin II; Angiotensins; Blood Pressure; Drug Therapy; Epinephrine; Geriatrics; Humans; Infusions, Parenteral; Mortality; Myocardial Infarction; Shock	1964
Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 2003, Oct-28, Volume: 108, Issue:17 Topics: Angiotensin II; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Genetic Therapy; Heart Failure; Humans; Immunohistochemistry; Male; Matrix Metalloproteinases; Mice; Muscle, Skeletal; Myocardial Infarction; Myocardium; Sequence Deletion; Survival Rate; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling	2003
Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro. Cardiovascular research, 2003, Dec-01, Volume: 60, Issue:3 Topics: Angiotensin II; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Autocrine Communication; Biglycan; Extracellular Matrix Proteins; Fibroblasts; Gene Expression; Losartan; Myocardial Infarction; Myocardium; Proteoglycans; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta	2003
Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium. Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:4 Topics: Angiotensin II; Animals; Arterioles; Capillaries; Chemotaxis, Leukocyte; Collateral Circulation; Cytokines; Enzyme Inhibitors; Granulocytes; Macrophages; Male; Mice; Mice, Knockout; Myocardial Infarction; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Sarcoma 180; T-Lymphocytes; Ventricular Remodeling	2004
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Coronary Vessels; Disease Models, Animal; Enzyme Induction; Imidazoles; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ventricular Remodeling	2004
Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. Journal of molecular and cellular cardiology, 2004, Volume: 36, Issue:3 Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Cardiac Output, Low; Cells, Cultured; Connective Tissue Growth Factor; Fibroblasts; Gene Expression; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents	2004
The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning. Cardiovascular research, 2004, Apr-01, Volume: 62, Issue:1 Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Genistein; Glycine; Hydroxamic Acids; Immunoblotting; Ischemic Preconditioning, Myocardial; Metalloendopeptidases; Myocardial Infarction; Naphthalenes; Perfusion; Phosphorylation; Protein-Tyrosine Kinases; Rabbits; Signal Transduction; Tumor Necrosis Factor-alpha	2004
Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circulation research, 2004, Apr-02, Volume: 94, Issue:6 Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Baroreflex; Brain; DNA, Antisense; Genes, Synthetic; Glial Fibrillary Acidic Protein; Heart Rate; Hypothalamus; Injections, Intraventricular; Male; Myocardial Infarction; Organ Size; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reflex, Abnormal; Renin-Angiotensin System; Stress, Psychological; Stroke Volume; Sympathetic Nervous System; Transgenes; Ventricular Dysfunction, Left; Ventricular Remodeling	2004
Evidence of the role of angiotensin AT(1) receptors in remote renal preconditioning of myocardium. Methods and findings in experimental and clinical pharmacology, 2004, Volume: 26, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Body Temperature; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Heart Rate; Injections, Intravenous; Ischemia; Ischemic Preconditioning, Myocardial; Kidney; Losartan; Male; Myocardial Infarction; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renal Artery; Reperfusion; Time Factors	2004
Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation, 2004, May-11, Volume: 109, Issue:18 Topics: Alkaloids; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Benzophenanthridines; Cell Movement; Cells, Cultured; Cysteine-Rich Protein 61; Flavonoids; Gene Expression Regulation; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interleukin-6; Leukemia Inhibitory Factor; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Naphthalenes; Neovascularization, Physiologic; Norepinephrine; Paracrine Communication; Phenanthridines; Phenylephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Stress, Mechanical; Telmisartan; Tumor Necrosis Factor-alpha	2004
Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovascular research, 2004, Oct-01, Volume: 64, Issue:1 Topics: Angiotensin II; Animals; Blood Volume; Dogs; Echocardiography; Heart Failure; Hemodynamics; Microcirculation; Myocardial Infarction; Natriuretic Peptide, Brain; Phosphopyruvate Hydratase; Time Factors; Ventricular Function	2004
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade. Canadian journal of physiology and pharmacology, 2004, Volume: 82, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium; Calcium-Transporting ATPases; Captopril; Cyclic AMP-Dependent Protein Kinases; Enalapril; Heart Failure; Imidazolidines; Losartan; Male; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors	2004
Oxidative stress in the infarcted heart: role of de novo angiotensin II production. Biochemical and biophysical research communications, 2004, Dec-17, Volume: 325, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Heart Ventricles; Losartan; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tissue Distribution; Treatment Outcome	2004
Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. Journal of cardiovascular pharmacology, 2005, Volume: 45, Issue:1 Topics: Adrenergic beta-Agonists; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Canrenoic Acid; Fibrosis; Heart Failure; Isoproterenol; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta	2005
Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture. Journal of leukocyte biology, 2005, Volume: 78, Issue:1 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cells, Cultured; Coronary Artery Disease; Dinoprostone; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypertension; Imidazoles; Matrix Metalloproteinase 1; Monocytes; Myocardial Infarction; Oligopeptides; Phosphoprotein Phosphatases; Pyridines; Receptor, Angiotensin, Type 2; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation	2005
The angiotensin II type 2 receptor and improved adjacent region function post-MI. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2005, Volume: 7, Issue:2 Topics: Angiotensin II; Animals; Collagen; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Heart Ventricles; Image Processing, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Receptor, Angiotensin, Type 2; Stroke Volume; Systole; Ventricular Dysfunction, Left; Ventricular Remodeling	2005
Altered fibroblast function following myocardial infarction. Journal of molecular and cellular cardiology, 2005, Volume: 39, Issue:4 Topics: Angiotensin II; Animals; Autoantibodies; Cell Adhesion; Cell Movement; Cell Proliferation; Collagen; Discoidin Domain Receptors; Endothelin-1; Female; Fibroblasts; Heart Ventricles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Animal models of cardiac fibrosis. Methods in molecular medicine, 2005, Volume: 117 Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; Heart Ventricles; Humans; Immunohistochemistry; In Situ Hybridization; Isoproterenol; Male; Myocardial Infarction; Myocardium; Phenotype; Rats; Rats, Sprague-Dawley; RNA, Messenger	2005
Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:1 Topics: Angiotensin II; Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Collagen Type I; Collagen Type III; Collagen Type VI; Coronary Vessels; Extracellular Matrix; Fibroblasts; Fibrosis; Ligation; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Ventricular Remodeling	2006
Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside. Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Angiotensin I; Angiotensin II; Antihypertensive Agents; Coronary Disease; Drug Synergism; Female; Humans; Male; Myocardial Infarction; Nitric Oxide Donors; Nitroprusside; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasoconstrictor Agents	2005
Angiotensin II AT1 receptor density on blood platelets predicts early left ventricular remodelling in non-reperfused acute myocardial infarction in humans. European journal of heart failure, 2006, Volume: 8, Issue:2 Topics: Aged; Angiotensin II; Blood Platelets; Cholesterol, LDL; Diabetes Complications; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Radioligand Assay; Receptor, Angiotensin, Type 1; Regression Analysis; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling	2006
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation, 2005, Nov-08, Volume: 112, Issue:19 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Fibrosis; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Protein Serine-Threonine Kinases; Quaternary Ammonium Compounds; rho-Associated Kinases; Vascular Diseases	2005
Scar myofibroblasts of the infarcted rat heart express natriuretic peptides. Journal of cellular physiology, 2006, Volume: 207, Issue:1 Topics: Adrenomedullin; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Cicatrix; Colforsin; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression; Isoproterenol; Male; Myocardial Infarction; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptides; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serine Endopeptidases	2006
Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats. Life sciences, 2006, May-22, Volume: 78, Issue:26 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Captopril; Hemodynamics; Kidney; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Mineralocorticoid; RNA, Messenger	2006
Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:6 Topics: Adiponectin; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endothelin-1; Endothelins; Image Processing, Computer-Assisted; Immunohistochemistry; Myocardial Infarction; Myocytes, Cardiac; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Receptors, Cell Surface; RNA, Messenger; RNA, Small Interfering; Transfection; Tumor Necrosis Factor-alpha	2006
Angiotensin preconditioning of the heart: evidence for redox signaling. Cell biochemistry and biophysics, 2006, Volume: 44, Issue:1 Topics: Acetophenones; Acetylcysteine; Angiotensin II; Animals; Antioxidants; Apoptosis; Gene Expression; Heart; Heart Rate; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Membrane Glycoproteins; Membrane Transport Proteins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Oxidation-Reduction; Perfusion; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling	2006
Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system. Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Shape; fas Receptor; Female; Heart; Myocardial Infarction; Myocardium; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Renin-Angiotensin System; Reperfusion Injury; Swine; Tetrahydroisoquinolines; Tumor Suppressor Protein p53	2006
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Cardiotonic Agents; Enzyme Inhibitors; Hemodynamics; Hypoglycemic Agents; Immunohistochemistry; Ligands; Male; Mitogen-Activated Protein Kinase 1; Myocardial Infarction; Myocardium; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones	2006
Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure. European journal of pharmacology, 2006, Jul-01, Volume: 540, Issue:1-3 Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Blotting, Western; Cell Enlargement; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Guanidines; Heart; Heart Failure; Hypertrophy; Mitogen-Activated Protein Kinases; Myoblasts; Myocardial Infarction; Myocardium; Organ Size; Potassium Channels, Inwardly Rectifying; Protein Precursors; Pyrans; Rats; Rats, Sprague-Dawley	2006
Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:4 Topics: Angiotensin II; Animals; Apoptosis; Blood Pressure; Body Weight; Cardiac Output; Caspase 3; Caspases; Enzyme Inhibitors; Heart; Indoles; Inflammation; Male; Mitogen-Activated Protein Kinase 14; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Wistar; Reperfusion Injury; Stroke Volume; Vasoconstrictor Agents	2006
Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Body Weight; Coronary Circulation; Exercise Test; Female; Irbesartan; Male; Myocardial Infarction; Myocardium; Norepinephrine; Organ Size; Oxygen; Physical Conditioning, Animal; Sus scrofa; Tetrazoles; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System	2006
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. American heart journal, 2006, Volume: 152, Issue:2 Topics: Aged; Aldosterone; AMP Deaminase; Angiotensin II; Atrial Natriuretic Factor; Endothelin-1; Epinephrine; Female; Genotype; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Norepinephrine; Polymorphism, Genetic; Proportional Hazards Models; Retrospective Studies	2006
Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction. International journal of cardiology, 2006, Oct-26, Volume: 113, Issue:1 Topics: Angiotensin II; Animals; Blood Glucose; Body Weight; Collagen; Insulin; Ligands; Liver; Lung; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Organ Size; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Ventricular Remodeling	2006
Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Enalapril; Hemodynamics; Male; Myocardial Infarction; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction; Ventricular Function, Left	2006
Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation, 2006, Aug-22, Volume: 114, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Humans; Myocardial Infarction; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Tumor Necrosis Factor-alpha	2006
Reviewer critique of the sympathetic drive after acute myocardial infarction in hypertensive patients. American journal of hypertension, 2006, Volume: 19, Issue:10 Topics: Acute Disease; Angiotensin II; Baroreflex; Blood Pressure; Female; Heart; Heart Rate; Humans; Hypertension; Insulin; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Sympathetic Nervous System	2006
The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 292, Issue:2 Topics: Angiotensin II; Animals; Cardiac Output, Low; Coronary Vessels; Disease Models, Animal; Enzyme Inhibitors; Heart Rate; Heart Ventricles; Imidazoles; Ligation; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Time Factors; Vasoconstriction; Vasodilator Agents; Ventricular Function, Left	2007
Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection. Cardiovascular research, 2007, Jan-01, Volume: 73, Issue:1 Topics: Androstadienes; Angiotensin II; Animals; Blotting, Western; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oncogene Protein v-akt; Perfusion; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Time Factors; Wortmannin	2007
Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats. Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:4 Topics: Angiotensin II; Animals; Blotting, Western; Body Weight; Enzyme-Linked Immunosorbent Assay; Heart; Male; Myocardial Contraction; Myocardial Infarction; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Time Factors; Ventricular Dysfunction; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling	2007
Influence of transplantation of allogenic bone marrow mononuclear cells on the left ventricular remodeling of rat after acute myocardial infarction. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2006, Volume: 26, Issue:6 Topics: Angiotensin II; Animals; Bone Marrow Transplantation; Collagen Type I; Disease Models, Animal; Leukocytes, Mononuclear; Male; Myocardial Infarction; Osteopontin; Rats; Rats, Wistar; Ventricular Remodeling	2006
Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:6 Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Cell Adhesion Molecules; Cell Communication; Cells, Cultured; Disease Models, Animal; Fibroblasts; Gene Expression Regulation; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Random Allocation; Rats; Rats, Inbred Lew; Rats, Wistar; Stress, Mechanical; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2007
Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Collagen; Fibrosis; Gene Expression Regulation; Heart; Heart Rate; Macrophages; Male; Mice; Mice, Transgenic; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Ventricular Remodeling	2007
[Comparative study on early application of the recipe for activating blood circulation and the recipe for supplementing qi for inhibiting left ventricular remodeling and apoptosis in rats with heart failure]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2007, Volume: 32, Issue:8 Topics: Angiotensin II; Animals; Apoptosis; Astragalus propinquus; Drug Combinations; Drugs, Chinese Herbal; Heart Failure; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Plants, Medicinal; Qi; Random Allocation; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Ventricular Remodeling	2007
Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2007, Volume: 8, Issue:2 Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Heart; Insulin; Losartan; Myocardial Infarction; Organ Size; Rats; Receptor Cross-Talk; Receptor, Insulin; Receptors, Angiotensin; Reference Values	2007
Avoiding vicious circles: mineralocorticoid receptor antagonism prevents vascular oxidative stress early after myocardial infarction. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Endothelium, Vascular; Eplerenone; Humans; Mice; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Oxidative Stress; Rats; Signal Transduction; Spironolactone	2007
Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelins; Hemodynamics; Irbesartan; Myocardial Infarction; Oxygen; Physical Exertion; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Tetrazoles; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation; Ventricular Function, Left; Ventricular Remodeling	2008
Reduction of ischemic, pharmacological and remote preconditioning effects by an antioxidant N-acetyl cysteine pretreatment in isolated rat heart. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:3 Topics: Acetylcysteine; Angiotensin II; Animals; Cardiotonic Agents; Female; Free Radical Scavengers; Hydrogen Peroxide; In Vitro Techniques; Ischemic Preconditioning; Male; Myocardial Infarction; Oxidation-Reduction; Rats; Rats, Wistar; Reactive Oxygen Species	2008
Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:3 Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cells, Cultured; Collagen; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Imidazoles; Myocardial Infarction; Myocytes, Cardiac; Neoplasm Proteins; Organ Size; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling	2008
Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:6 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Brain; Fibrosis; Hemodynamics; Indoles; Infusions, Intravenous; Injections, Subcutaneous; Kidney; Lisinopril; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Renin-Angiotensin System; Sympathetic Nervous System; Ventricular Dysfunction, Left	2008
Role of angiotensin II in the altered renal function of congestive heart failure. Circulation research, 1984, Volume: 55, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Myocardial Infarction; Rats; Renal Circulation	1984
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. The Annals of thoracic surgery, 1995, Volume: 60, Issue:3 Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles	1995
Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:3 Topics: Angiotensin II; Animals; Enzyme Activation; Female; Hemodynamics; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Protein Kinase C; Rabbits	1995
Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. Journal of cardiovascular risk, 1994, Volume: 1, Issue:3 Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Disease Models, Animal; Heart; Heart Failure; Hemodynamics; Imidazoles; Isoquinolines; Losartan; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Tetrahydroisoquinolines; Tetrazoles	1994
Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovascular research, 1994, Volume: 28, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Biphenyl Compounds; Collagen; Fibrosis; Foreign-Body Reaction; Imidazoles; Lisinopril; Losartan; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles	1994
Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction. Circulation research, 1994, Volume: 75, Issue:3 Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Membrane; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Heart; Heart Failure; Kidney; Lung; Male; Myocardial Infarction; Organ Size; Peptidyl-Dipeptidase A; Pleural Effusion; Rats; Rats, Wistar; Renin; RNA, Messenger	1994
Length-dependent modulation of ANG II inotropism in rat myocardium: effects of myocardial infarction. The American journal of physiology, 1994, Volume: 266, Issue:2 Pt 2 Topics: Amino Acid Sequence; Angiotensin II; Animals; Cardiotonic Agents; Humans; Isometric Contraction; Male; Molecular Sequence Data; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Rats; Rats, Sprague-Dawley; Reference Values; Ventricular Function, Left	1994
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation, 1994, Volume: 89, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Enalapril; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors	1994
Effects of LTD4 and its specific antagonist L-660,711 in isolated rat hearts with chronic myocardial infarction. The American journal of physiology, 1994, Volume: 266, Issue:5 Pt 2 Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Bronchodilator Agents; Coronary Circulation; Heart; Heart Rate; In Vitro Techniques; Leukotriene D4; Male; Myocardial Infarction; Organ Size; Propionates; Quinolines; Rats; Rats, Wistar; Time Factors; Ventricular Function, Left	1994
Short- and long-term neurohormonal activation following acute myocardial infarction. American heart journal, 1993, Volume: 126, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Case-Control Studies; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Posture; Renin-Angiotensin System; Sympathetic Nervous System; Thrombolytic Therapy; Time Factors	1993
Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs. British journal of pharmacology, 1993, Volume: 110, Issue:3 Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Disease Models, Animal; Dogs; Enalaprilat; Female; Furosemide; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Renin-Angiotensin System; Tetrazoles	1993
Contractile function of right ventricular papillary muscle after left ventricular infarction in rats: effects of early and late inhibition of angiotensin converting enzyme. European heart journal, 1993, Volume: 14, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Male; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Rats; Rats, Wistar; Ventricular Function, Right	1993
Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. Journal of molecular and cellular cardiology, 1993, Volume: 25, Issue:11 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Hemodynamics; Indans; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles	1993
Alterations in ANG II responsiveness in left and right myocardium after infarction-induced heart failure in rats. The American journal of physiology, 1993, Volume: 264, Issue:6 Pt 2 Topics: Angiotensin II; Animals; Cardiac Output, Low; Hemodynamics; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Papillary Muscles; Rats; Rats, Sprague-Dawley	1993
Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovascular research, 1993, Volume: 27, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Blotting, Northern; Disease Models, Animal; Heart Failure; Kidney; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System	1993
Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovascular research, 1993, Volume: 27, Issue:2 Topics: Angiotensin II; Animals; Benzamidines; Bradykinin; Captopril; Dogs; Guanidines; Hemodynamics; Male; Myocardial Infarction; Oligopeptides; Serine Proteinase Inhibitors	1993
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition. European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Electrophysiology; Female; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Rabbits; Ramipril; Tetrazoles	1993
[Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction]. Journal of cardiology, 1995, Volume: 26, Issue:5 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Chronic Disease; Cilazapril; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume	1995
Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:9 Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Base Sequence; Benzimidazoles; Biphenyl Compounds; DNA, Complementary; Gene Expression; Male; Molecular Sequence Data; Myocardial Infarction; Myosin Heavy Chains; Rats; Rats, Wistar; Tetrazoles; Transforming Growth Factor beta	1995
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. Circulation, 1996, Apr-15, Volume: 93, Issue:8 Topics: Acute Disease; Angiotensin II; Animals; Blood Vessels; Cardiac Output; Compliance; Coronary Circulation; Disease Models, Animal; Dogs; Female; Hemodynamics; Hypertension; Male; Myocardial Infarction; Myocardial Ischemia; Vascular Resistance	1996
Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovascular research, 1996, Volume: 31, Issue:4 Topics: Angiotensin II; Animals; Autoradiography; Fibroblasts; Fibrosis; Immunohistochemistry; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Time Factors	1996
Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. The American journal of physiology, 1996, Volume: 270, Issue:6 Pt 2 Topics: Adult; Aged; Angiotensin II; Animals; Cell Separation; Female; Guinea Pigs; Humans; Isoenzymes; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Myosins; Perfusion; Rats; Rats, Sprague-Dawley; Sarcomeres	1996
Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. The American journal of physiology, 1996, Volume: 271, Issue:2 Pt 2 Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Endothelium, Vascular; Femoral Artery; Hemodynamics; In Vitro Techniques; Indoles; Male; Myocardial Infarction; Nitroprusside; Perindopril; Rats; Rats, Wistar; Vasodilator Agents	1996
Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Heart; Indoles; Male; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley	1996
Cardiac angiotensin converting enzyme and endothelin receptor in rats with chronic myocardial infarction. Japanese circulation journal, 1996, Volume: 60, Issue:12 Topics: Angiotensin II; Animals; Autoradiography; Cardiomegaly; Chronic Disease; Endothelin-1; Female; Heart Failure; Image Processing, Computer-Assisted; Iodine Radioisotopes; Ligation; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptors, Endothelin; Renin; Ventricular Function, Left	1996
Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Hemodynamics; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	1996
Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II. Atherosclerosis, 1997, Feb-10, Volume: 128, Issue:2 Topics: Angiotensin II; Animals; Aorta; Aortic Diseases; Blood Pressure; Daboia; Drug Synergism; Female; Hyperlipidemias; Male; Myocardial Infarction; Necrosis; Rabbits; Reference Values; Serotonin; Thrombosis; Tunica Media; Viper Venoms	1997
Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling. Circulation, 1997, Mar-04, Volume: 95, Issue:5 Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diastole; Femoral Artery; Heart; Heart Failure; Hemodynamics; In Vitro Techniques; Lisinopril; Male; Muscle, Smooth, Vascular; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Survival Rate; Vascular Resistance; Ventricular Function, Left	1997
Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. The Journal of laboratory and clinical medicine, 1997, Volume: 129, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Fibrosis; Imidazoles; Losartan; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles	1997
Angiotensin and bradykinin peptides in rats with myocardial infarction. Journal of cardiac failure, 1997, Volume: 3, Issue:1 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Kidney; Lung; Male; Myocardial Infarction; Myocardium; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin	1997
[Does a genetic predisposition for infarction expansion exist? Evaluation of genetic polymorphisms of the renin-angiotensin system]. Cardiologia (Rome, Italy), 1997, Volume: 42, Issue:3 Topics: Aged; Alleles; Angiotensin II; Angiotensinogen; Causality; Confidence Intervals; Echocardiography; Female; Genes; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Angiotensin; Renin-Angiotensin System	1997
Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:7 Topics: Angiotensin II; Animals; Cattle; Cells, Cultured; Fibroblasts; Fluorescent Antibody Technique, Indirect; Gene Expression; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta	1997
Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats. American journal of hypertension, 1997, Volume: 10, Issue:8 Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Heart Rate; Hemodynamics; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Inbred SHR	1997
Increased angiotensin-converting enzyme activity in the left ventricle after infarction. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1997, Volume: 30, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Heart Rate; Heart Ventricles; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System	1997
Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction. The American journal of physiology, 1997, Volume: 273, Issue:3 Pt 2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Arterioles; Coronary Vessels; Endothelin-1; Hemodynamics; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocardial Infarction; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Time Factors; Vasoconstriction; Vasoconstrictor Agents	1997
Role of the angiotensin II type 1 receptor in preconditioning against infarction. Coronary artery disease, 1997, Volume: 8, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Rabbits; Radioimmunoassay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles	1997
Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovascular research, 1997, Volume: 35, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biomarkers; Blotting, Northern; Collagen; Hydrogen-Ion Concentration; Hydroxyproline; Immunohistochemistry; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ventricular Function, Left	1997
Effects of angiotensin II on cardiac function and peripheral vascular structure during compensated heart failure in the rat. Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:10 Topics: Angiotensin II; Animals; Blood Pressure; Blood Vessels; Heart; Male; Myocardial Infarction; Rats; Rats, Wistar	1997
Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period. Journal of the American College of Cardiology, 1997, Volume: 30, Issue:7 Topics: Angiotensin II; Animals; Animals, Newborn; Body Weight; Endothelin-1; Female; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Factors; Sex Factors; Tobacco Smoke Pollution	1997
Effect of the novel angiotensin II type 1 receptor antagonist L-158,809 on acute infarct expansion and acute anterior myocardial infarction in the dog. The Canadian journal of cardiology, 1998, Volume: 14, Issue:1 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Disease Models, Animal; Dogs; Echocardiography; Imidazoles; Myocardial Infarction; Random Allocation; Tetrazoles; Ventricular Function, Left	1998
Species variability in angiotensin receptor expression by cultured cardiac fibroblasts and the infarcted heart. The American journal of physiology, 1998, Volume: 274, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Calcium; Cell Membrane; Cells, Cultured; Collagen; Fibroblasts; Hypertension; Myocardial Infarction; Myocardium; Rabbits; Radioligand Assay; Rats; Receptors, Angiotensin; Species Specificity; Time Factors	1998
[Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling]. Arquivos brasileiros de cardiologia, 1997, Volume: 69, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Heart; Heart Ventricles; Hemodynamics; Hydroxyproline; Losartan; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Proteins; Rats; Rats, Inbred Strains; Rats, Wistar; Vasoconstrictor Agents	1997
Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circulation research, 1998, Jun-15, Volume: 82, Issue:11 Topics: Angiotensin II; Animals; Cardiomegaly; Cell Size; Cells, Cultured; Male; Microscopy, Confocal; Muscle Fibers, Skeletal; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Up-Regulation; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Function, Right	1998
Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. Journal of molecular and cellular cardiology, 1998, Volume: 30, Issue:8 Topics: Angiotensin II; Animals; Collagen; Fibrosis; Losartan; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Transforming Growth Factor beta	1998
Increased expression of glomerular AT1 receptors in rats with myocardial infarction. The American journal of physiology, 1998, Volume: 275, Issue:4 Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Down-Regulation; Gene Expression Regulation; Kidney Cortex; Kidney Glomerulus; Kinetics; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values; Renal Circulation; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Up-Regulation	1998
Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction. Journal of cardiac failure, 1998, Volume: 4, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Blood Flow Velocity; Body Weight; Diastole; Drug Therapy, Combination; Echocardiography; Female; Growth Hormone; Hemodynamics; Hypertrophy, Left Ventricular; Kidney; Liver; Losartan; Myocardial Infarction; Myocardium; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Spleen; Ventricular Function, Left; Ventricular Remodeling	1998
Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts. The American journal of physiology, 1998, Volume: 275, Issue:5 Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Electrophysiology; Heart Ventricles; Hydrogen-Ion Concentration; Myocardial Contraction; Myocardial Infarction; Rabbits; Receptors, Angiotensin; Signal Transduction; Vasoconstrictor Agents	1998
Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these dis European heart journal, 1998, Volume: 19, Issue:11 Topics: Aged; Angiotensin II; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Angiotensin; Risk Factors	1998
Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. The American journal of physiology, 1999, Volume: 276, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Heart Ventricles; Isoquinolines; Male; Myocardial Infarction; Myocardium; Nephrectomy; Quinapril; Rats; Rats, Wistar; Renin; Tetrahydroisoquinolines	1999
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomegaly; Cyclic GMP; Drug Synergism; Indoles; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Perindopril; Potassium; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan	1999
Role of angiotensin in cardioprotective effect of ischemic preconditioning. Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Creatine Kinase; Female; Heart Rate; Imidazoles; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Tetrazoles	1999
Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. The American journal of physiology, 1999, Volume: 276, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Brain; Cardiotonic Agents; Enzyme Inhibitors; Guanabenz; Heart Failure; Heart Rate; Injections, Intraventricular; Losartan; Male; Myocardial Infarction; Nitroprusside; Ouabain; Phenylephrine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stress, Physiological; Sympathetic Nervous System	1999
Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation, 1999, May-25, Volume: 99, Issue:20 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Cardiomegaly; Fibrosis; Gene Expression; Heart; Heart Ventricles; Male; Myocardial Infarction; Myocardium; Norepinephrine; Rats; Rats, Wistar; Steroids	1999
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:3 Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Heart Ventricles; Humans; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Tetrazoles; Time Factors	1999
Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. The American journal of physiology, 1999, Volume: 277, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Brain; Cardenolides; Glycosides; Heart; Hemodynamics; Hyperemia; Hypertension; In Vitro Techniques; Male; Myocardial Infarction; Rats; Rats, Wistar	1999
Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study. Scandinavian cardiovascular journal : SCJ, 1999, Volume: 33, Issue:6 Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Catecholamines; Creatine Kinase; Echocardiography, Doppler; Heart Atria; Heart Ventricles; Humans; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prognosis; Protein Precursors; Radioimmunoassay	1999
Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. Journal of the American College of Cardiology, 2000, Mar-01, Volume: 35, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Captopril; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Losartan; Myocardial Infarction; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Treatment Outcome; Ventricular Fibrillation	2000
Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit. Italian heart journal : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:2 Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Aspirin; Creatine Kinase; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Peroxidase; Rabbits; Vasoconstrictor Agents; Ventricular Function, Left	2000
Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death. The American journal of pathology, 2000, Volume: 156, Issue:5 Topics: Angiotensin II; Animals; Apoptosis; Body Weight; Cell Death; Cell Size; Cells, Cultured; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Stress, Mechanical; Time Factors; Up-Regulation	2000
[Refractory shock after converting enzyme inhibitor administration. Usefulness of angiotensin II]. Presse medicale (Paris, France : 1983), 2000, Apr-08, Volume: 29, Issue:13 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Female; Fluid Therapy; Humans; Lisinopril; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance; Vasoconstrictor Agents	2000
Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation. Circulation, 2000, Jul-25, Volume: 102, Issue:4 Topics: Angiotensin II; Animals; Ischemic Preconditioning; Male; Myocardial Infarction; Rabbits; Receptors, Angiotensin; Signal Transduction; Ventricular Remodeling	2000
Update of recent clinical trials in heart failure and myocardial infarction. European journal of heart failure, 1999, Volume: 1, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design	1999
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition. European journal of pharmacology, 2000, Jul-21, Volume: 400, Issue:2-3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart; Losartan; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasculitis	2000
Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation, 2000, Sep-26, Volume: 102, Issue:13 Topics: Angiotensin II; Animals; Captopril; Models, Cardiovascular; Myocardial Infarction; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine	2000
Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure. Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiac Output; Chronic Disease; Echocardiography; Female; Heart; Heart Failure; Imidazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organ Size; Ramipril; Stroke Volume; Tetrazoles; Ventricular Remodeling	2000
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. American heart journal, 2000, Volume: 140, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Myocardial Infarction; Odds Ratio; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Sample Size; Tetrazoles; Valine; Valsartan	2000
Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:6 Topics: Active Transport, Cell Nucleus; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Cardiomegaly; Cell Nucleus; Cells, Cultured; Collagen; Cytosol; DNA-Binding Proteins; Fibroblasts; Heart Failure; In Vitro Techniques; Losartan; Male; Myocardial Infarction; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Smad2 Protein; Smad4 Protein; Trans-Activators; Transforming Growth Factor beta; Vimentin	2000
Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart. Basic research in cardiology, 2000, Volume: 95, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Dogs; Heart; Hemodynamics; Injections, Intravenous; Irbesartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Tetrazoles	2000
Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clinical chemistry, 2000, Volume: 46, Issue:12 Topics: Adult; Age of Onset; Angiotensin II; Angiotensinogen; Apolipoproteins E; Cholesterol; Genotype; Humans; Lipoproteins, HDL; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Risk Factors; Triglycerides	2000
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor. British journal of pharmacology, 2001, Volume: 132, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium-Binding Proteins; Calpain; Disease Models, Animal; Gene Expression Regulation; Heart; Heart Rate; Imidazoles; Male; Myocardial Infarction; Protein Biosynthesis; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Transcription, Genetic; Valine; Valsartan	2001
Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Coronary Vessels; DNA; DNA-Binding Proteins; Drosophila Proteins; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Guanine Nucleotide Exchange Factors; Imidazoles; Imidazolidines; Immunoblotting; Janus Kinase 1; Janus Kinase 2; Male; Myocardial Infarction; Myocardial Ischemia; Peptidyl-Dipeptidase A; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Trans-Activators	2001
Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes. DNA and cell biology, 2000, Volume: 19, Issue:12 Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Disease Progression; Endothelin-1; Gene Expression Profiling; Gene Expression Regulation; Heart Ventricles; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Nonmuscle Myosin Type IIB; Oligonucleotide Array Sequence Analysis; Rats; RNA, Messenger; Transforming Growth Factor beta; Troponin I	2000
Effect of ethylisopropyl amiloride, a Na+ - H+ exchange inhibitor, on cardioprotective effect of ischaemic and angiotensin preconditioning. Molecular and cellular biochemistry, 2000, Volume: 214, Issue:1-2 Topics: Amiloride; Angiotensin II; Animals; Cardiovascular Agents; Creatine Kinase; Female; Hemodynamics; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Sodium-Hydrogen Exchangers	2000
Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction. Journal of cellular physiology, 2001, Volume: 187, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Becaplermin; Binding, Competitive; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Female; Fibroblasts; Immunohistochemistry; Losartan; Myocardial Infarction; Myocardium; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger	2001
High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium. Cardiology, 2000, Volume: 94, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Autopsy; Chymases; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Renin; Serine Endopeptidases	2000
Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction. Journal of the American College of Cardiology, 2001, Jun-15, Volume: 37, Issue:8 Topics: Angiotensin I; Angiotensin II; Animals; Bicarbonates; Blotting, Northern; Carrier Proteins; Male; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium-Bicarbonate Symporters; Sodium-Hydrogen Exchangers	2001
Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts. British journal of pharmacology, 2001, Volume: 134, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Coronary Circulation; Dose-Response Relationship, Drug; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Perfusion; Rats; Rats, Sprague-Dawley	2001
AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction. American journal of physiology. Heart and circulatory physiology, 2001, Volume: 281, Issue:6 Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiac Output; Coronary Circulation; Heart Failure; Heart Rate; Imidazoles; Irbesartan; Male; Myocardial Infarction; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Circulation; Survival Rate; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents; Vasodilation	2001
Blockade of angiotensin II type 1 receptors suppressed free radical production and preserved coronary endothelial function in the rabbit heart after myocardial infarction. Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:1 Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Enzyme Inhibitors; Free Radicals; Hemodynamics; In Vitro Techniques; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Nitroprusside; omega-N-Methylarginine; Oxygen; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tiopronin; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling	2002
Angiotensin II fails to induce preconditioning in vivo--the protective role of myocardial stretch due to pressure overload. The Canadian journal of cardiology, 2002, Volume: 18, Issue:1 Topics: Angiotensin II; Animals; Disease Models, Animal; Gadolinium; Hemodynamics; Infusions, Intravenous; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Pressure; Rabbits; Reference Values; Sensitivity and Specificity	2002
Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2001, Volume: 2, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Endothelial Growth Factors; Endothelium, Vascular; Female; Losartan; Lymphokines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Renin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilation	2001
Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:4 Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Cicatrix; Coronary Circulation; Extracellular Matrix; Female; Kinetics; Myocardial Infarction; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Time Factors; Tissue Distribution	2000
The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2002, Volume: 3, Issue:1 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Electrocardiography; Endothelial Growth Factors; Endothelium, Vascular; Female; Hemodynamics; Losartan; Lymphokines; Muscle, Smooth, Vascular; Myocardial Infarction; Nicotine; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Renin; Renin-Angiotensin System; Reperfusion Injury; Tobacco Smoke Pollution; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Ventricular Fibrillation	2002
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone. Journal of endocrinological investigation, 2002, Volume: 25, Issue:5 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Cardiomegaly; Cardiovascular System; Chronic Disease; Enalapril; Losartan; Male; Mesenteric Arteries; Myocardial Infarction; Rats; Rats, Wistar	2002
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age]. Schweizerische medizinische Wochenschrift, 1976, Dec-11, Volume: 106, Issue:50 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Catecholamines; Diuretics; Humans; Hypertension; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Renin; Vasodilator Agents	1976
[Relationship between the kininase- and angiotensin- converting activity under normal conditions and in experimental myocardial infarct]. Kardiologiia, 1977, Volume: 17, Issue:1 Topics: Acute Disease; Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Carboxypeptidases; Injections, Intra-Arterial; Injections, Intravenous; Kallidin; Lysine Carboxypeptidase; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Rats; Unithiol	1977
[Humoral mechanisms of renin-angiotensin system activation in macrofocal myocardial infarct]. Vrachebnoe delo, 1979, Issue:11 Topics: Adult; Aged; Angiotensin II; Angiotensinogen; Endopeptidases; Enzyme Activation; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Renin; Shock, Cardiogenic	1979
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. American heart journal, 1975, Volume: 89, Issue:3 Topics: Acute Kidney Injury; Adult; Angiotensin II; Animals; Cephaloridine; Female; Heart Diseases; Humans; Kidney; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Nephrectomy; Norepinephrine; Pyelonephritis; Rabbits; Renal Dialysis; Sodium Chloride; Urea	1975
[Renin and various factors of its regulation in acute myocardial infarct]. Kardiologiia, 1978, Volume: 18, Issue:5 Topics: Acute Disease; Adult; Aged; Aldosterone; Angiotensin II; Homeostasis; Humans; Hypokalemia; Male; Middle Aged; Myocardial Infarction; Potassium; Renin	1978
[Pathogenesis of the gastrointestinal syndrome in myocardial infarct]. Kardiologiia, 1976, Volume: 16, Issue:4 Topics: Adult; Aged; Angiotensin II; Capillaries; Capillary Permeability; Dyspepsia; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Kallikreins; Kinins; Male; Middle Aged; Myocardial Infarction; Peptic Ulcer; Renin	1976
Dissociation between indices of pump performance and contractility in patients with coronary artery disease and acute myocardial infarction. Chest, 1975, Volume: 67, Issue:2 Topics: Acute Disease; Angiocardiography; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Exercise Test; Heart; Heart Rate; Heart Ventricles; Humans; Indicator Dilution Techniques; Models, Biological; Myocardial Infarction	1975
Jeremiah Metzger lecture, 1974: The renin-angiotensin system. Some new aspects. Transactions of the American Clinical and Climatological Association, 1975, Volume: 86 Topics: Adult; Age Factors; Angiotensin II; Animals; Brain Chemistry; Cerebrovascular Disorders; Dogs; Humans; Hypertension; Isoenzymes; Middle Aged; Myocardial Infarction; Racial Groups; Rats; Renin; Sodium; Submandibular Gland	1975
Overall cardiovascular regulation. Annual review of physiology, 1976, Volume: 38 Topics: Afferent Pathways; Angiotensin II; Animals; Arteries; Blood Circulation; Blood Pressure; Cardiovascular Physiological Phenomena; Chemoreceptor Cells; Coronary Circulation; Efferent Pathways; Heart; Humans; Hypothalamus; Myocardial Contraction; Myocardial Infarction; Pressoreceptors; Pressure; Reflex; Renin; Spinal Cord; Sympathetic Nervous System; Vagus Nerve; Vasomotor System; Vasopressins	1976
Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cardiac Output; Collagen; DNA; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles	1992
Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation. Agents and actions. Supplements, 1992, Volume: 38 ( Pt 3) Topics: Angiotensin II; Animals; Benzamidines; Blood Pressure; Bradykinin; Captopril; Cardiac Output; Coronary Circulation; Coronary Vessels; Dogs; Guanidines; Heart; Hemodynamics; Kallikreins; Male; Myocardial Infarction; Myocardium; Vascular Resistance	1992
Dynamic determinants of left ventricular early diastolic filling in old myocardial infarction. Japanese circulation journal, 1992, Volume: 56, Issue:7 Topics: Adult; Aged; Angiotensin II; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Ventricular Function, Left	1992
[The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril]. Zhonghua xin xue guan bing za zhi, 1991, Volume: 19, Issue:6 Topics: Adult; Aged; Aldosterone; Angiotensin II; Captopril; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System	1991
Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure. American journal of hypertension, 1991, Volume: 4, Issue:4 Pt 2 Topics: Administration, Oral; Angiotensin II; Animals; Body Weight; Captopril; Cardiac Output, Low; Compliance; Disease Models, Animal; Dose-Response Relationship, Drug; Heart; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Tetrazoles; Ventricular Function, Left	1991
Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction. The American journal of cardiology, 1990, Sep-01, Volume: 66, Issue:5 Topics: Aged; Aldosterone; Angiotensin II; Cardiac Catheterization; Diuretics; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume	1990
Systemic neurohumoral activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris. The American journal of cardiology, 1991, Jul-15, Volume: 68, Issue:2 Topics: Adult; Aged; Angina Pectoris; Angiotensin II; Cardiac Pacing, Artificial; Catecholamines; Coronary Circulation; Dopamine; Electrocardiography; Epinephrine; Female; Humans; Lactates; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Vascular Resistance; Vasoconstriction	1991
Neuroendocrine activation in acute myocardial infarction. Journal of cardiovascular pharmacology, 1987, Volume: 9 Suppl 2 Topics: Aged; Angiotensin II; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Myocardium; Neurosecretory Systems; Renin-Angiotensin System	1987
Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction. Journal of cardiovascular pharmacology, 1987, Volume: 9 Suppl 2 Topics: Angiotensin II; Blood Pressure; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Wedge Pressure; Renin	1987
Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig. Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:2 Topics: Angiotensin II; Animals; Captopril; Coronary Disease; Electric Stimulation; Electrophysiology; Hemodynamics; Male; Myocardial Infarction; Swine; Tachycardia	1989
[Responsiveness of peripheral blood vessels to physiologically vasoactive agents in myocardial infarct]. Kardiologiia, 1989, Volume: 29, Issue:11 Topics: Adult; Aged; Angiotensin II; Blood Vessels; Epinephrine; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prognosis; Skin; Time Factors; Vasoconstrictor Agents; Vasodilator Agents	1989
Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. American heart journal, 1985, Volume: 109, Issue:2 Topics: Angiotensin II; Animals; Coronary Circulation; Creatine Kinase; Dipeptides; Enalaprilat; Heart Ventricles; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Renin-Angiotensin System	1985
[Platelet function in patients with acute myocardial infarction]. Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1988, Volume: 87, Issue:1 Topics: Aged; Angiotensin II; Blood Platelets; Epinephrine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Thromboxanes	1988
Role of the kidney in congestive heart failure. Acta medica Scandinavica. Supplementum, 1986, Volume: 707 Topics: Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rate; Heart Failure; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Natriuresis; Rats; Rats, Inbred Strains; Renal Circulation	1986
Role of angiotensin II in the altered renal function of heart failure. Kidney international. Supplement, 1987, Volume: 20 Topics: Angiotensin II; Animals; Denervation; Glomerular Filtration Rate; Heart Failure; Kidney; Kidney Cortex; Male; Microcirculation; Myocardial Infarction; Rats; Rats, Inbred Strains; Renin-Angiotensin System	1987
Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet (London, England), 1971, Jul-03, Volume: 2, Issue:7714 Topics: Acute Kidney Injury; Angiotensin II; Animals; Bicarbonates; Body Weight; Creatinine; Diagnosis, Differential; Diuretics; Injections, Intravenous; Kidney; Kidney Tubules; Myocardial Infarction; Potassium; Rabbits; Rats; Renin; Sodium; Time Factors; Urea; Uremia	1971
Angiotensin, myocardial infarction, and strokes. Lancet (London, England), 1972, Jun-10, Volume: 1, Issue:7763 Topics: Adult; Angiotensin II; Animals; Cerebrovascular Disorders; Female; Humans; Hypertension; Middle Aged; Myocardial Infarction; Rabbits; Renin	1972
[Blood plasma content of angiotensinogen in arterial hypertension, circulatory insufficiency, myocardial infarct and liver cirrhosis]. Kardiologiia, 1972, Volume: 12, Issue:2 Topics: Adrenal Glands; Alpha-Globulins; Angiotensin II; Chronic Disease; Glomerulonephritis; Glucocorticoids; Heart Failure; Humans; Hypertension; Liver; Liver Cirrhosis; Myocardial Infarction; Renin	1972
Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension. Lancet (London, England), 1973, Sep-01, Volume: 2, Issue:7827 Topics: Adult; Aged; Angiotensin II; Black People; Cerebrovascular Disorders; Creatinine; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Potassium; Radioimmunoassay; Renin; Retrospective Studies; Sodium	1973
Letter: Prolactin and myocardial infarction. Lancet (London, England), 1973, Dec-01, Volume: 2, Issue:7840 Topics: Angiotensin II; Arrhythmias, Cardiac; Female; Heart; Humans; Male; Myocardial Infarction; Norepinephrine; Prolactin; Radioimmunoassay	1973
[Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock]. Bibliotheca cardiologica, 1966, Volume: 17 Topics: Angiotensin II; Animals; Coronary Disease; Dogs; Electrocardiography; Epinephrine; Heart; Heart Rate; Humans; Isoproterenol; Mephentermine; Metaraminol; Myocardial Infarction; Norepinephrine; Shock; Vascular Resistance	1966
[Results of treatment of myocardial infarction associated with shock in relation to the kind of administered drugs]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1968, May-06, Volume: 23, Issue:19 Topics: Adult; Aged; Angiotensin II; Epinephrine; Female; Humans; Hydrocortisone; Male; Middle Aged; Morphine; Myocardial Infarction; Shock; Strophanthins	1968
Results of treatment of myocardial infarction accompanied by shock in relation to drugs applied. Polish medical journal, 1969, Volume: 8, Issue:2 Topics: Adult; Aged; Angiotensin II; Female; Humans; Hydrocortisone; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Shock	1969
[Incidence of cardiogenic shock in patients with acute myocardial infarct. A few remarks on mortality and therapeutic possibilities]. Casopis lekaru ceskych, 1969, May-23, Volume: 108, Issue:22 Topics: Angiotensin II; Cardiac Output; Female; Humans; Injections, Intravenous; Male; Myocardial Infarction; Norepinephrine; Shock	1969
[Importance of regional circulation for treatment of cardiogenic shock]. Arzneimittel-Forschung, 1969, Volume: 19, Issue:5 Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Arteries; Blood Pressure; Cardiac Output; Dogs; Epinephrine; Heart Rate; Hemodynamics; Humans; Lactates; Metaproterenol; Myocardial Infarction; Oxygen Consumption; Pyruvates; Regional Blood Flow; Shock; Vascular Resistance; Veins	1969
[Effect of hypoxia of the myocardium on the reactivity of the coronary vessels]. Kardiologiia, 1969, Volume: 9, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Coronary Vessels; Dogs; Electrocardiography; Epinephrine; Hypoxia; Lobeline; Methods; Myocardial Infarction; Perfusion; Serotonin; Vascular Resistance; Veratrine	1969
Left ventricular function during the early and late stages of scar formation following experimental myocardial infarction. American heart journal, 1970, Volume: 79, Issue:3 Topics: Angiotensin II; Animals; Cardiac Catheterization; Cardiac Output; Dogs; Dye Dilution Technique; Electrocardiography; Heart Function Tests; Heart Rate; Heart Ventricles; Hemodynamics; Myocardial Infarction	1970
Postinfarction myocardial hypersensitivity to naturally occurring humoral agents in dogs. The American journal of the medical sciences, 1970, Volume: 260, Issue:2 Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Drug Hypersensitivity; Epinephrine; Female; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Male; Myocardial Infarction; Norepinephrine; Vasopressins	1970
Experimental left ventricular akinesis: results of excision. The Journal of thoracic and cardiovascular surgery, 1970, Volume: 60, Issue:5 Topics: Acetylcholine; Angiocardiography; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cineangiography; Disease Models, Animal; Dogs; Electric Countershock; Extracorporeal Circulation; Heart Ventricles; Hemodynamics; Isoproterenol; Myocardial Infarction; Pulmonary Edema; Ventricular Fibrillation	1970
[Problems in the treatment of cardiogenic shock]. Das Deutsche Gesundheitswesen, 1970, Apr-23, Volume: 25, Issue:16 Topics: Angiotensin II; Humans; Myocardial Infarction; Norepinephrine; Shock, Cardiogenic; Vasoconstrictor Agents	1970
[Problem of cardiogenic shock therapy]. Kardiologiia, 1970, Volume: 10, Issue:7 Topics: Adrenal Cortex Hormones; Analgesics; Angiotensin II; Anticoagulants; Assisted Circulation; Benperidol; Cardiac Glycosides; Dextrans; Fibrinolytic Agents; Humans; Hydrocortisone; Myocardial Infarction; Neuroleptanalgesia; Norepinephrine; Phenoxybenzamine; Shock, Cardiogenic	1970
Acute circulatory failure secondary to myocardial infarction. Postgraduate medicine, 1971, Volume: 49, Issue:5 Topics: Angiotensin II; Blood Pressure; Carbon Dioxide; Central Venous Pressure; Ephedrine; Hemodynamics; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Metaraminol; Methoxamine; Myocardial Infarction; Norepinephrine; Oxygen; Partial Pressure; Phenylephrine; Regional Blood Flow; Shock, Cardiogenic	1971
[Nuclear medicine in the diagnosis of heart diseases]. Naika. Internal medicine, 1971, Volume: 28, Issue:2 Topics: Angiography; Angiotensin II; Digitalis Glycosides; Heart Diseases; Humans; Krypton; Lung Diseases; Molybdenum; Myocardial Infarction; Potassium Isotopes; Radioisotope Dilution Technique; Radioisotopes; Radionuclide Imaging; Serum Albumin, Radio-Iodinated; Technetium	1971
New thoughts on essential hypertension. British medical journal, 1972, Apr-15, Volume: 2, Issue:5806 Topics: Angiotensin II; Cerebrovascular Disorders; Humans; Hypertension; Myocardial Infarction; Renin	1972
Experimental myocardial ischemia and infarction. Production of diffuse myocardial lesions in unanesthetized calves. The American journal of cardiology, 1972, Volume: 29, Issue:6 Topics: Angiotensin II; Animals; Aorta; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cattle; Coronary Vessels; Creatine Kinase; Disease Models, Animal; Electrocardiography; Heart Rate; Injections, Intra-Arterial; Lactates; Methods; Microspheres; Myocardial Infarction	1972
Left ventricular akinesis: experimental production, haemodynamic effects, and results of excision. Cardiovascular research, 1972, Volume: 6, Issue:4 Topics: Acetylcholine; Angiocardiography; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cineangiography; Dogs; Heart; Heart Rate; Heart Ventricles; Isoproterenol; Muscle Contraction; Myocardial Infarction; Myocardium	1972
Heart attacks: possible risk factor. Proceedings of the National Academy of Sciences of the United States of America, 1972, Volume: 69, Issue:7 Topics: Adrenal Cortex Hormones; Angiotensin II; Arteriosclerosis; Blood Vessels; Humans; Hypertension; Hypertension, Malignant; Myocardial Infarction; Renin	1972
Low-renin hypertension. The New England journal of medicine, 1973, May-17, Volume: 288, Issue:20 Topics: Angiotensin II; Black People; Cerebrovascular Disorders; Humans; Hypertension; Myocardial Infarction; Radioimmunoassay; Renin; Sodium	1973
Vasospasm in ischemic heart disease--a hypothesis. Perspectives in biology and medicine, 1973,Spring, Volume: 16, Issue:3 Topics: Angina Pectoris; Angiotensin II; Animals; Arterial Occlusive Diseases; Blood Platelets; Catecholamines; Coronary Disease; Dogs; Female; Fibrinolysis; Humans; Male; Myocardial Infarction; Renin; Stress, Psychological	1973
Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction. Circulation, 1973, Volume: 47, Issue:6 Topics: Adult; Angiography; Angiotensin II; Assisted Circulation; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Angiography; Electrocardiography; Female; Heart Auscultation; Heart Rate; Heart Septum; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Infarction; Oxygen; Papillary Muscles; Pulmonary Artery; Rupture; Shock, Cardiogenic	1973
Renin in hypertension: how important as a risk factor? Canadian Medical Association journal, 1973, Sep-15, Volume: 109, Issue:6 Topics: Adult; Angiotensin II; Aortic Aneurysm; Aortic Rupture; Blood Pressure; Cerebrovascular Disorders; Creatinine; Follow-Up Studies; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Middle Aged; Myocardial Infarction; Posture; Potassium; Renal Artery Obstruction; Renin; Sodium; Urea	1973
[Certain mechanisms of hemodynamic disorders in acute myocardial infarct (experimental study)]. Kardiologiia, 1974, Volume: 14, Issue:8 Topics: Angiotensin II; Animals; Blood Pressure; Blood Pressure Determination; Cardiac Output; Cardiac Volume; Coronary Circulation; Coronary Vessels; Heart; Hemodynamics; Injections, Intravenous; Myocardial Infarction; Rabbits; Rats	1974
[Evaluation of the left and right ventricular function in acute myocardial infarct at the moment of dismissal]. Bollettino della Societa italiana di cardiologia, 1972, Volume: 17, Issue:9 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Heart; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction	1972